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IDENTIFICATION AND CHARACTERIZATION OF SUPPRESSORS OF
HOPMl; A PLANT PATHOGEN EFFECTOR OF PSEUDOMONAS
SYRINGAE PV. TOMATO DC3000
Vanessa Revindran, Ph.D.
Western Michigan University, 2012
We have created a yeast model system to study the
action of the plant pathogen effector HopMl in
Saccharomyces cerevisiae. Pseudomonas syringae, causative
agent of bacterial speck in tomatoes, utilizes the type
III secretion system to shuttle the effector proteins
into the host cell.
When expressed in yeast, HopMl is lethal on solid
media at 21 °C, but not at 30° C and 37 ° C.

The same

temperature sensitive ability of HopMl to cause death on
solid media is also observed in liquid.

As demonstrated

by SDS PAGE-Western blot analysis, HopMl protein is
present at 21 °C, 30° C and 37 °C. At 21 °C, a full-length
protein of 78kDA is observed. At 30° C and 37°C, the
majority of HopMl protein exists as degraded fragments.
HopMl containing strains were visualized using the VS
epitope and irnrnunofluorescent microscopy. HopMl localizes
to mitochondria and secretory organelles. This result was
confirmed using cellular fractionation and sucrose

gradient density centrifugation. When plated on media
containing glycerol, we observed no change in expression
of HopMl, thus indicating that is it unlikely that
binding to mitochondria results in the lethal phenotype.
We have isolated 19 spontaneous s�ppressor strains
that are capable of surviving the HopMl imposed lethality
at 21 ° C. All strains have been examined for HopMl protein
expression, of which 13 express full-length HopMl at
21 ° C, and 5 do not.

SupMl-16, showed a significant

increase in growth rates as compared to the wild type
strain expressing HopMl. None of the suppressor strains
show a change in localization of HopMl as compared to
wild type. One of the suppressor strains, SupMl-16 was
sequenced to identify the gene(s) responsible for the
suppression phenotype. Six genes that may be the
suppressor gene were identified. The most likely
candidate is RSP5; an E3 Ubiquitin Ligase. RSP5 contains
a single mutation that changes a Glycine to Valine in the
HECT domain. Overall our findings suggest that HopMl
kills the yeast cell by perturbing a secretory pathway
regulator and that mutation of RSP5 alters HopMl effects
on this pathway to allow survival.
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CHAPTER 1

INTRODUCTION

All around the globe, people go hungry every day.

In

2009, it was estimated that more than·1 billion people went
without food (Food and Agriculture Organization of the
United Nations, 2009).

The United Nations estimates that

about 850 million people go to bed hungry each night, and
of that, 50 million are in the United States (Fighting
Hunger Worldwide, 2010, World Hunger Education Services,
2010).
There are many causes as to why many people are left
without food. Among them; having being hit by natural
disasters such as earthquakes and storms, violence and war
and the fact that there is just not enough food to
accommodate the demand. Besides that, the persistently high
price of food and low production due to crop loss are also
important reasons as to why people go hungry every day
(Fighting Hunger Worldwide, 2010, Rosegrant, 2008, World
Hunger Education Services, 2010).
The increasing use of crops for non-food purposes has
become a contributing factor to the decrease in the amount
of food available. The usage of food crop for biofuel
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production has taken its toll on the amount available for
consumption. The reason biofuels have gained a lot of
attention stems from the fact that biofuels can be
harvested from crops easily grown by farmers (Doornbosch
and Steenblik, 2008). On top of that, the sheer increase in
demand for and production of biofuels ·has had a significant
impact on the supply and demand for food crop as biofuels
(Rosegrant, 2008).
Another huge factor that contributes to the decrease
of food crops available for consumption is due to plant
disease. Worldwide crop loss due to plant disease has been
estimated as 36.5% of production capacity (Agrios, 2005).
These losses are much higher in developing countries and
much lower in developed countries. It has been estimated
that of the 36.5% of the average crop loss, 14.1% is caused
by pathogens, 10.2% by insects and 12.2% by weeds. These
numbers put the total of annual worldwide crop loss from
plant disease at $220 billion (Agrios, 2005). In the United
States alone, it has been estimated that crop loss due to
disease is worth $9.1 billion (Agrios, 2005).
Finding drugs or compounds capable of reducing
pathogen effect and even preventing it, would help increase
food crop production. This is due to the fact that with the
advent of biotechnology and with the discovery of biofuels,
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farmers have slowly begun to increase the price of crops
(Koh and Ghazoul, 2008, Pimentel et al., 2009). Many
farmers are solely looking at producing crop for biofuel
purposes, thus taking away from the total amount of food
crop available for consumption (Koh and Ghazoul, 2008).
Plant Diseases

Plant diseases are caused by many factors, among them
abiotic and biotic stress. Abiotid stressors are caused by
non-living factors, such as drought stress, sunscald,
freeze and wind injury, chemical drift, nutrient deficiency
and even improper practices such as overwatering and
planting too deep (Grant et al., 2006, Mittler, 2006).
Living organisms such as fungi, bacteria, viruses,
nematodes, insects, mites and animals are the main culprits
behind biotic stress. (Grant et al., 2006, Mudgett, 2005).
Insects cause serious damage by chewing, and by doing so,
induce a wound response that includes the production of
protease inhibitors and alkaloids (Dangl and Jones, 2001).
Nematodes on the other hand have a more refined method of
parasitism. They do so by administering a developmental
response on plant cells that inadvertently lead to the
growth of galls, cysts or root knots (Dangl and Jones,
2001).
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Three critical factors need to be present in order for
plant disease to occur, a susceptible host plant, a biotic
stressor and the ideal environmental conditions. The
interaction that occurs between these 3 components is known
as the udisease triangle" (Agrios, 2005). If a virulent
pathogen is introduced into a susceptible host lacking
optimal environmental conditions, disease development may
be prevented (Parker and Gilbert, 2004). There are many
routes of entry for a pathogen into its host. For example,
viruses invade a plant cell intracellularly and mycelium
are produced and grow through the host cell in the case of
fungi. (Buttner and Bonas, 2002 and Galan and Collmer,
1999).
Plant Basal Defense

Plants have evolved numerous ways to respond to
exterior attacks. Among them are preformed barriers such as
thicker waxy cuticles, trichomes (specialized epidermal
cells that are present in most plants and usually appear as
fine hairs on the exterior), presence of secondary
metabolites (chemical compounds that are very distinct from
the intermediates and the products of primary metabolism),
and an inducible basal defense response that is able to
suppress pathogen/microbe growth (Alfano and Collmer, 1997,
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Bennett and Wallsgrove, 1994, Levin, 1973). Plants have
also evolved the ability that allows them to act as
suppressors of programmed cell death, suppressors of plant
cell wall remodeling, and as activators of the Jasmonic
Acid pathway (Alfano and Collmer, 1997� Greenberg and
Vinatzer, 2003, Loake, 2001, Mudgett, 2005).
Programmed Cell Death (PCD)

Programmed Cell Death (PCD), is a physiological
process of cell death that is performed by the plant. It
involves the destruction of cells that are damaged and not
functioning correctly (Greenberg, 1996, Greenberg, 1997,
Pennell and Lamb, 1997). This process is necessary for
growth and survival in plants, and occurs locally and
sometimes even on a wider scale (Pennell and Lamb, 1997).
Plants are capable of recognizing certain pathogens and
upon recognition defenses that result in the limitation of
pathogen growth are activated (Greenberg, 1996, Greenberg,
1997). Programmed cell death is therefore an essential
process in safeguarding proper plant development and in
ensuring that appropriate defense responses are elicited
against pathogens (Greenberg, 1996, Greenberg, 1997).
Recent studies have shown that both AvrPto and AvrPtoB
(both effector proteins of Pseudomonas syringae) interrupt
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the Pto disease resistance pathways by acting as a
suppressor of PCD (Abramovitch and Martin 2005, Abramovitch
et al., 2003, Jamir et al., 2003, Loake, 2001, Mudgett
2005). AvrPto and AvrPtoB interrupt the Pto disease pathway
by interacting with the Pto serine/threonine kinase, a
resistance protein in tomatoes. Once AvrPto and AvrPtoB are
recognized in the tomato host, the Prf-dependent signal
transduction pathway is activated and this leads to disease
resistance by the elicitation of the Hypersensitive
Response (Abramovitch et al., 2003, Mudgett, 2005, Pedley
and Martin, 2003). In N. benthamiana however, the
expression of AvrPtoB and AvrPto fails to elicit the
Hypersensitive Response. The Hypersensitive Response (HR)
is defined as cell death that is localized at the site of
infection during an incompatible interaction between a
resistant plant and an avirulent pathogen (Dangl and Jones,
2001, He, 1996). These results therefore indicate that
AvrPtoB may act as a specific suppressor of the Pto pathway
in N. benthamiana but not in tomatoes (Mudgett, 2005,
Pedley and Martin, 2003).
Plant Cell Wall Remodeling

The plant cell wall is the first layer of the d_efense
that is encountered by a pathogen when trying to gain
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access into a plant (Maor and Shirasu, 2005). Upon attack,
the plant reinforces its cell wall in order to slow down or
even prevent pathogen attack. Reinforcement of the cell
wall is done via callose deposition (callose is a sugar
polymer that consists of 1-3-�-D-glucan subunits) at the
site of attack (Maor and Shirasu, 2005). Another way in
which plants defend themselves against pathogen attack is
by remodeling and repairing wounds to their cell walls by
forming thick protrusions known as papillae or even by the
production of wound plugs (Alfano and Collmer, 1996, Bent,
1996, Hauck et al., 2003).
The effector protein AvrPto blocks the induction of
papillae formation via the Salicylic acid independent
pathway (Grant et al., 2006, Hauck et al., 2003, Mudgett,
2005). Besides AvrPto, HopMl and AvrE are also the other
known effectors of Pseudomonas syrinage pv. tomato that are
capable of suppressing the papillae formation by preventing
the deposition of callose at the site of wounding/infection
(Alfano and Collmer, 1996, Lindgren, 1997, Mudgett, 2005,
Nomura et al., 2006).
Salicylic Acid and Jasmonic Acid Pathway

Salicylic Acid plays an important role as the plant
signaling molecule that is responsible for both local and
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systemic induced disease resistance (Durner et al., 1997,
Mudgett, 2005). The local induced resistance is expressed
as a hypersensitive response through the growth of lesions
that prevent the pathogen from spreading (Pieterse and van
Loon, 1999). Jasmonic Acid on the other hand is a signaling
hormone that is induced and immediately produced as a
response to herbivores and wounding (Clarke et al., 2000,
Pieterse and van Loon, 1999, Wasternack et al., 2006, Zhao
et al., 2003,). The activation of JA signaling suppresses
the SA signaling pathway, thus making plants more
susceptible to pathogen attack (Mudgett, M.B., 2005).
Salicylic Acid signaling is required for effective
defense against pathogen infection in Pseudomonas syringae
(Clarke et al., 2000, Grant et al., 2006, Mudgett, 2005).
The phytotoxin Coronatine (COR), which is found in
Pseudomonas syringae, acts as a mimic of JA, and suppresses

the SA signaling pathways, thus preventing the pathogen
from being killed (Brooks et al., 2005, Duner et al., 1997,
Mudgett, 2005).
Resistance Protein Activation

Resistance proteins or sometimes referred to as R
proteins, play a key role in the defense signal
transduction pathways (Mudgett, 2005). These resistance
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proteins recognize a matching pathogen avirulence protein
and confer upon the plant the specific innate immunity
(Takken at al., 2006, 2009). There are numerous classes of
R proteins, among which are Pto-Serine/Threonine Kinases,
Leucine Rich Repeat-Nucleotide Binding Sequence-Leucine
Zipper motifs and Extracellular Leucine Rich Repeats (Bent
and Mackey, 2007, Takken et al., 2006, 2009).
Many pathogens have however evolved numerous ways to
suppress the host basal defense responses (Takken et al.,
2006, 2009). One well-studied example is the suppression of
the RIN4 regulated basal defense by Pseudomonas syringae in
Arabidopsis (Lim et al., 2004, Mudgett, M. B., 2005, Takken
et al., 2006). The effector AvrRpt2 of Pseudomonas syringae
pv. tomato plays a role in suppressing the activation of
the RPMl-dependent disease resistance pathway in
Arabidopsis (Bent, 1996, Bretz and Hutcheson, 2004, Chen et
al., 2000, ,Lim and Kunkel, 2004, Takken et al., 2000,
2006, 2009). The RPMl-dependent disease resistance pathway
functions by recognizing the presence of the effector
protein AvrRpt2 (Maor and Shirasu, 2005, Mudgett, 2005).
AvrRpt2 causes the proteolysis of RIN4; a protein that is
required for RPMl mediated disease resistance (Lim and
Kunkel, 2004). The R protein RPS2 monitors the regulation
of RIN4. With the elimination of RIN4, RPMl is not
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activated as presence of RIN4 is required for RPMl disease
resistance activation (Mudgett, 2005, Maor and Shirasu,
2005, Lim and Kunkel, 2004).
The Plant Immune System

Mobile defender cells and a somatic adaptive immune
system, found in mammals, are lacking in plants (Jones and
Dangl, 2006). Despite this, plants are still able to
exhibit a response to a f?reign invader. Plants not only
rely upon the innate immunity of each cell but also on the
systemic signals emitted from infection sites (Jones and
Dangl, 2006).
Plants have evolved mechanisms to detect pathogen
invaders. These are known as pathogen- or microbe
associated molecular patterns (PAMPS or MAMPS) (Jones and
Dangl, 2006). Some examples of MAMPS are components of the
bacterial flagella, fungal chitin, cold-shock proteins,
lipopolysaccharides, hairpins, peptidoglycans and
elongation factor Tu (Bittel and Robatzek, 2007, Jones and
Dangl, 2006, Zhou and Chai, 2008). Host pathogen
recognition receptors (PRR) are located on the cell surface
and upon MAMPS recognition, they trigger a basal defense
response (also known as PAMP-triggered immunity (PTI))
(Jones and Dangl, 2006). The basal defense response that is
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triggered by the host pathogen recognition receptors is
usually effective at preventing infection. In plants, this
basal defense response involves the induction of MAPK
signaling cascades, calcium flux, nitric oxide and reactive
oxygen species production, the thickening of the cell wall
and stress-WRKY transcription factor activation (Mccann and
Guttman, 2007).
Pathogens have evolved a mechanism to slip past the
plants immunity. Many pathogens are capable of deploying
effectors that contribute towards the pathogens virulence
(Jones and Dangl, 2006). With the process of evolution,
both plants and pathogens have developed numerous ways of
overcoming the response elicited by the other. The deployed
effectors interfere with the signaling pathways that result
in the activation of the PTI and result in an effector
triggered susceptibility (ETS) (Jones & Dangl, 2006
McDowell and Simon, 2009). Plants have nucleotide binding
(NB) and Leucine rich repeats (LRR) that are capable of
recognizing the deployed effectors and in turn help
contribute towards the effector-triggered immunity (ETI)
(Zhou & Chai, 2008).
The ETI is an amplified and accelerated PTI response,
and usually results in a hypersensitive cell death response
at the site of pathogen infection (Jones and Dangl, 2006).
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Through the process of natural selection, the pathogens are
driven to avoid the ETI and this is done by shedding or
diversifying the recognized effector gene, or even by
acquiring additional effectors that are capable of
suppressing the ETI (Jones and Dangl, 2006 Zhou & Chai,
2008).
Type III effectors are the only known proteins in
bacterial pathogens that can elicit the ETI (Block et al.,
2008, Jones and Dangl, 2006). There is some overlap in the
signaling pathways that occur between the ETI and PTI. The
direct recognition of an effector by an R protein may lead
to the ETI. According to the guard hypothesis however, many
R proteins detect the modifications of the host targets
made by the specific effectors, and in many cases it is not
just the recognition of the presence of effectors (Block et
al., 2008 and Jones and Dangl, 2006).
Phytopathogens

Phytopathogenic bacteria infect plants using a
multitude of methods. They make use of the numerous
secretions systems, among them the type I, II, III, IV, V
and VI secretion systems. Despite this, all have in common
the goal of getting the pathogen inside the plant cell and
making sure the plant defenses are inactivated. For
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example, Erwinia amylovora that causes fire blight and
Erwinia chrysanthemi use the Type I Secretion System
(Guttman, 2004), whereas Agrobacterium tumafaciens and
Xanthomonas campestris pv. vesicatoria use the Type IV
Secretion System (Guttman, 2004). The most common genera of
gram negative bacterial phytopathogens are Pseudomonas,
Xanthomonas, Ralstonia, Erwinia and Pantoea, and all of
these phytopathogens make use of the Type III Secretion
System to inject their virulence factors into their host
cells (Alfano and Collmer, 1996, Bretz and Hutcheson, 2004,
Collmer et al, 2002, Grant et �l., 2006, He et at., 2004,
Mudgett, 2005).
All pathogens that utilize the Type III Secretion
system can be divided into 2 groups based on highly
conserved core structural component similarity (Galan and
Collmer, 1999). The first group is composed of predicted
outer membrane proteins and also includes proteins that
have sequence similarity to the secretin family of protein
transporters. This group also includes components that have
several less conserved lipoproteins (Galan and Collmer,
1999). The other group comprises integral membrane proteins
that are comparable to components of the flagellar export
apparatus (Galan and Collmer, 1999).

13

The Pseudomonas syringae spp. and Erwinia spp. are
classified as group I, and Ralstonia and Xanthomonas spp.
are classified as group II. Pseudomonas syringae pv. tomato
is more closely related to the Yersinia spp. than it is to
the Xanthomonas spp. (Preston, 2001). Each strain of
bacteria causes a different type of disease. For example,
Pseudomonas syringae pv. tomato causes bacterial speck,
Erwinia carotovora causes soft rots, and Ralstonia
solanacearum causes vascular wilt (Collmer et al., 2000).
Pseudomonas syringae

Pseudomonas syringae is a plant-associated bacterium
that is found as a harmless symbiont on the surface of
leaves. When optimum conditions are present, it is able to
cause significant agricultural and economic concern (Sarkar
and Guttman, 2003). Pseudomonas syringae is a seed borne
phytopathogen that survives as a saprophyte in the soil,
plant debris and on leaf surfaces. Leaf wetness and cool
temperatures of around 13-25°C (Pedley and Martin, 2003) are
favorable for the development of disease symptoms such as
black leaf spots and dark specks on tomato that become
sunken (Pedley and Martin, 2003, Preston, 2001).
More than 50 pathogenic strains or pathovars of
Pseudomonas syringae have been identified based on their
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host specificity (Sarkar and Guttman, 2003). Among them are
Pseudomonas syringae pathovar syringae that causes
bacterial brown spots in beans, Pseudomonas syringae
pathovar phaseolicola that causes halo blight on beans,
Pseudomonas syringae pathovar maculicola that causes
bacterial leaf spots on cruciferous plants and Pseudomonas
syringae pathovar tomato DC3000 that causes bacterial speck
in tomatoes (Buell et al., 2003, Collmer et al., 2000).
Pseudomonas syringae spp. are motile, rod-shaped gram
negative aerobes (Preston, 2001). Pseudomonas syringae
pathovar tomato has been completely sequenced and annotated
(Buell et al., 2003), thus making it the most studied of
all Pseudomonas syringae strains. A reason to why this
strain is frequently studied is the ease at which this
pathogen is cultured and manipulated using a wide range of
molecular genetics and cell biology techniques. Another
crucial reason as to why this is a frequently studied
strain is due to it being pathogenic to the model plant
Arabidopsis thaliana (Preston, 2001).
The genome of Pseudomonas syringae pathovar tomato
DC3000 is 6.5 megabases, contains a circular chromosome and
2 plasmids that encode for 5763 open reading frames (Buell
et al., 2003). 298 virulence genes have been identified,
including various clusters of genes that encode for the 31
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confirmed and 19 predicted effector proteins (Buell et al.,
2003). Analysis looking for similarity among Pseudomonas
spp. has shown a high degree of similarity between
Pseudomonas syringae pathovar tomato DC300 with Pseudomonas
putida and Pseudomonas aeruginosa. However, there are still
1159 genes that are unique to Pseudom6nas syringae pathovar
tomato DC3000, 811 of which lack any known function (Beull
et al., 2003).
Type III Secretion System

Many gram-negative bacteria, including Pseudomonas
syringae use the Type III Secretion System (TTSS) to inject
effector proteins into host cells. Pseudomonas syringae
pathovar tomato DC3000 uses the Hrp pilus to shuttle/inject
its virulence factors across the plant cell wall into the
plant cytoplasm (Alfano and Coilmer 1997, Buttner and Bonas
2002, 2006, Yuan and He 1996). The hrp pilus is more
flexible and measures between 6-Bnm in diameter by 2µm in
length. When compared to the TTSS in animal pathogens, the
animal needle is a more stiff structure, roughly around
80nm in length (Bretz and Hutcheson 2004, Galan and Collmer
1999). This is likely due to the structural hindrances that
the plant pathogen must deal with; it has a much greater
distance to traverse across the thick plant cell wall.
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The Type III secretion system pathway is encoded by
hrp (HR and eathogenicity) and hrc (HR and £Onserved)
genes. Lindgren et al. first identified Hrp genes in 1986
in Pseudomonas syringae pathovar syringae (Lindgren et al.,
1986). Hrp genes are clustered, spanning up to 41kb of DNA
and located on the chromosome (Van Gijsegem et al., 1995).
The biochemical functions of these hrp genes are unclear
but man� show similarity with other known genes. Molecular
and biochemical characterization research performed on the
hrp genes of numerous Pseudomonas syringae strains have
provided evidence to show that the hrp genes function in
protein secretion and gene regulation (He, 1996).
The hrc proteins direct the secretion of TTSS
substrates across the bacterial envelope and some of them
are secreted by the TTSS and direct the translocation of
effectors through host cell barriers. The designation of
Hop (grp 2uter eroteins) has been given to effectors that
are capable of migrating across the TTSS pathway (Alfano
and Collmer, 2004).
Translocation Apparatus

The secretion/translocation apparatus is constructed
upon expression of activated hrp genes (Jin et al., 2003,
Yuan and He, 1996, Collmer et al., 2000). The hypothesis

17

that both the type III secretion system and the flagella
are related stems from the similarity among the eight hrc
gen.es and the flagella assembly genes. Since the discovery
of the Hrp pilus in Pseudomonas syringae in 1997, similar
discoveries have been made in Ralstonia solanacearum,
Erwinia amylovora, Xanthomonas campestris and Sinorhizobium
fredii (He and Jin, 2003, Jin et al., 2003).
The major subunits of the pili are small sized
proteins of around 6 to llkDa that are sometimes referred
to as pilins (He and Jin, 2003). HrpA, which is the major
subunit of the Hrp pilus, is a 113-amino acid protein (Yuan
and He, 1996). HrpA is essential in causing the elicitation
of the HR in plants. The C-terminus of the HrpA is
responsible for the formation of the pili and for
virulence, whereas the N-terminus is not needed in the
formation of the filamentous pili (Yuan and He, 1996). It
has been shown in many studies that the presence of a
functional HrpA protein is required for the secretion of
the HrpZ hairpin (Grant et al., 2006, Mudgett, 2005, Yuan
and He, 1996).
There is significant difference in sequence, even
among the different strains of Pseudomonas syringae.
Mutants of Pseudomonas syringae pv. tomato DC300 that
contain a hrpA deletion mutation, lack the capability to
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produce the Hrp pilus and secrete HrpW and AvrPto (Jin, et
al., 2003).

It has been shown that all plant pathogens

secrete hairpin proteins but this is not true in animal
pathogens, thus this leads to the suggestion that these
hairpin proteins are somehow involved in helping with the
penetration of the TTSS pilus through.the plant cell wall
(He and Jin, 2003, Yuan and He, 1996).
There is mounting evidence that points at the Hrp
pilus being an essential part in protein delivery (He and
Jin, 2003). The HrpA genes of Pseudomonas syringae are
required for the extracellular secretion of effector
proteins. As shown by He et al., 2003, via an immunogold
labeling experiment, the secreted proteins HrpZ, HrpW and
AvrPto are colocalized along the length of the Hrp pilus
and not found just anywhere in the extracellular space (He
et al., 2003).
Type III secretion occurs at the site of the pilus
assembly and effector protein are secreted while the pilus
is being constructed (Li et al., 2002). Two alternative
models have been proposed to explain the localization of
the secreted proteins along the length of the pilus. The
first model, which is the "conduit" model, states that the
effector proteins are secreted as the Hrp pilus grows in
length, leaving behind a trail marking the growth of the
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pilus (He et al., 2004, Q Jin et al., 2001,). The other
model, which is known as the "guiding filament/conveyor
model", states that the Hrp pilus carries the effector
proteins with it as it grows out of the Type III secretion
basal body (He et al., 2004, Li et al., 2002).
Type III Secretion System in Phytopathogens

In phytopathogens the TTSS is known as the Hrp system
(gypersensitive Eesponse and Eathogenicity). The nature of
the name comes from the Hypersensitive Response (HR), which
it causes in plants (Alfano and Collmer, 1996, Bretz and
Hutcheson, 2004, Collmer et al., 2000, Collmer et al.,
2002, He, 1996). The TTSS has many unique features, among
which specific chaperones are required for the secretion of
effector proteins (Greenberg and Vinatzer, 2003, He et al.,
2004). Another unique feature is that the TTSS consists of
two parts, a base and the filamentous appendage, which in
animal pathogens are called the needle and in plant
pathogens are called the pilus (Alfano and Collmer, 1996,
Alfano and Collmer, 1997, Bretz and Hutcheson, 2004, Galan
and Collmer, 1999, He et al., 2004, Romantschuk et at.,
2001).
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Hairpins

All plant pathogens secrete proteins that are part of
the hairpin family (Alfano and Collmer, 1996). There are no
known mammalian pathogens that secrete these hairpins.
Hairpins are hydrophilic, heat-stable acidic proteins, rich
in glycine but cysteine-free that are·secreted when the Hrp
system is expressed (Li, 2007, Alfano and Collmer, 1996).
When present at high concentration in the plant apoplast,
the hairpin proteins elicit the HR. They travel through the
secretion apparatus but are not injected into the host
cell. They are however released into the apoplastic space.
Hairpin proteins have also been suggested to be involved in
assisting the Hrp pilus in penetrating the plant cell wall
(Alfano and Collmer, 1996, He, 2004).
Chaperones

Type III effector proteins require the use of
chaperone proteins to be translocated into the host cell.
These proteins are acidic in nature, rich in leucine and
are roughly about 170 amino acids in length, and contain an
amphipathic � helix near the C-terminus (Jin et al., 2003).
At present, there are three known classes of type III
secretion chaperones (Parsot et al., 2003, Jin et al.,
2003). Class I chaperones are involved in the binding of
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the effector protein at the chaperone binding domain (CBD),
which is located within the first 100 amino acids of the
effector protein (Akeda and Galan, 2005). Class I
chaperones are further divided into 2 classes, Class IA and
Class IB (Parsot at al., 2003, Kabisch et al., 2005). Class
IA chaperones interact with either one or several
homologous effectors and are encoded next to their
interaction partners, whereas Class IB chaperones are
capable of binding with a wide raQge of effectors (Kabisch
et al., 2005, Parsot et al., 2003). Chaperones classified
under Class II are involved in the translocation apparatus
formation. Class III chaperones are chaperones of the
flagellar system (Parsot et el., 2003). Genes that are
usually found on pathogenicity islands encode the type III
secretion system chaperones.
Chaperones are required for translocation and
secretion of the effectors and sometimes function to
protect the effectors from proteolysis or aggregation in
the bacterial cytoplasm (Jin et al., 2003). They however
are not required for the secretion of proteins produced due
to conditions of down regulation activity (Jin et al.,
2003, Parsot et al., 2003); Chaperones switch from their
bound state where they are bound to their specific effector
to a free state upon activation of secretion (Parsot et
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al., 2003). Upon secretion, chaperones release their bound
effectors, as they themselves are not secreted into the
host cell, and must remain within the bacterial cytoplasm
(Akeda and Galan, 2005).
The type III secretion chaperones play numerous roles.
They play a role as anti-folding factors, where they
function to maintain the effectors they associate with in
an unfolded state (Kabisch et al., 2005, Parsot et al.,
2003). The translocation channel is only about 2- 2.5nm in
diameter and thus is too small to allow a fully folded
effector to pass through it. Therefore, in order to pass
thru the channel, the effector proteins have to be
maintained in a semi or completely unfolded state (Parsot
et al., 2003, Kabisch et al., 2005).
Besides functioning as anti-folding factors, the
chaperones also function as secretion signals and as
stability factors (Parsot et al., 2003). The effector
protein YopE of Yersinia, in the absence of its chaperone
SycE, is unstable and undergoes rapid degradation (Mota et
al., 2005). In the plant pathogen Erwinia amylovora,
chaperone DspF is required for the stability of DspE (He,
2004). A recent study done in Pseudomonas syringae showed
that the chaperones protect their respective effectors from
Lon-associated degradation (Losada and Hutcheson, 2005).
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Most of the type III secretion system plant pathogenic
bacteria chaperones were discovered in Erwinia amylovora
and Pseudomonas syringae. These chaperones are specific for
one or several individual effectors (Parsot et al., 2003,
Badel et al., 2003). HrpG however, is the exception to
this. HrpG binds and inhibits the cytosolic HrpV protein,
which is a negative regulator of hrp gene expression.
Therefore HrpG is the first of the type III secretion
chaperones in plant pathogenic bacteria to have a
regulatory role (Buttner, 2006). At present, not much is
known about the chaperones of Pseudomonas syringae pv.
tomato DC3000. ShcSl and Shc0l are the two chaperones of
Pseudomonas syringae pv. tomato DC3000 that have been most
studied.

Hrp Outer Proteins

Type III effector proteins are proteins that are
secreted via the type III secretion system into the host
plant in order to overcome the host's defenses. In the case
of plant pathogens, the effectors function within the plant
cell and many appear to be post-transcriptionally modified
by the host enzymes. Pseudomonas syringae pv. tomato DC3000
has over 30 effector proteins that are the focus of many
studies (Buell et al., 2003, Grant, 2006). Among them are
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AvrPtoB or also known as HopAB2, HopAOl and HopMl, HopQl-1,
HopUl and many others. I will briefly talk about AvrPtoB,
HopAOl and HopMl, with the focus of this study being HopMl.
AvrPtoB

AvrPtoB or also widely known as HopAB2, is a 553 amino
acid protein (Abramovitch et al., 2003, Xiao et al., 2007).
It is a widely conserved effector protein found in numerous
Pseudomonas syringae strains as well as in Xanthomonas spp.
and Erwinia spp. It was first identified based on its
ability to trigger immunity on resistant tomato plants
expressing Pto and Prf and was therefore recognized as an
avirulence protein (Abramovitch, et al., 2003, Xiao et at.,
2007).
AvrPtoB has been determined to have 2 distinct
avirulence factors that are found in the N-terminal region
(Abramovitch et al., 2003). The first one is contained
within amino acid 1-307, is recognized by Pto Kinase, an R
protein, and the second one which is contained within amino
acids 1-187, is recognized by the R protein Fen kinase. The
C-terminal region of AvrPtoB is an E3 ligase which
ubiquinates the host R protein Fen, thus promoting its
degradation and causes disease susceptibility (Abramovitch
et al., 2003, Xiao et al., 2007, Xiang et al., 2008).
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AvrPtoB 1 _307 in susceptible tomato plants is sufficient
in promoting bacterial growth and enhancing disease
symptoms that is associated with an increase in ethylene
production (Xiao et al., 2007). In Arabidopsis, it has been
shown that AvrPtoB 1 _387 is required for the suppression of
pathogen associated molecular pattern ·triggered immunity.
Due to the fact that the activity of AvrPtoB 1 _301r AvrPtoB 1 _381r
and full length AvrPtoB is indistinguishable from each
other, this indicates that residues 308-553 have a
redundant phenotype or lacks virulence activity in tomatoes
(Xiao et al., 2007).
HopAOl

HopAOl (also known as HopPtoD2) is a 468 amino acid
protein (Alfano and Collmer, 1996, Brentz et al., 2003,
Grant et al., 2006, Underwood et al., 2007). The C terminal
of HopAOl contains a protein tyrosine phosphatase (PTP)
domain. This effector shares some homology with the
effector protein SptP that is found in Salmonella and the
effector protein YopH of Yersinia. The N terminal domain of
HopAOl shows some resemblance to that of another effector,
HopPtoD that has no predicted protein function (Grant et
al., 2 O O 6, Dean, 2 O 11) •
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It has been shown that the 321 amino acid terminal
domain alone is not effective in eliciting or affecting
plant defense responses, and that therefore the carboxyl
terminal domain is responsible for the activity of this
effector (Bretz et al., 2003, Dean, 2011). The exact role
of HopAOl in plants remains unclear, but it plays an
important role in Pseudomonas host interactions. As
suggested by Nurnberger and Schell, 2001 and Zhang and
Klessig, 2001, a possible target for the PTP activity of
HopAOl is one or more of the MAPK dependent signal
transduction pathways that controls defense responses.
In susceptible hosts such as Arabidopsis and tomato,
mutants of HopAOl show a reduced growth rate (Mudgett,
2005). In resistant hosts, hydrogen peroxide production and
PRl expression is decreased, and the HR initiation is
blocked. HopAOl also suppresses the HR that is induced in
Nicotiana benthamiana.

HopMl

HopMl (also known as HopPtoM) is a 712 amino acid
protein (Block et al., 2008, Block et al., 2011). The
effector protein HopMl is conserved among all strains of
Pseudomonas syringae. There are no known domains present in

HopMl nor does it share any homology with any other known
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proteins. HopMl has been shown to interfere with vesicle
trafficking (Nomura et al., 2006, Nomura et al., 2011,
Thordal-Christensen, 2009). As vesicle transport is
important for the export of defense compounds to the cell
wall and apoplast, its disruption would most certainly
impair cell wall based defenses (Block et al., 2008,
Thordal-Christensen, 2009).
HopMl is found in the endomembrane fraction of plant
cells in Arabidopsis. HopMl targets the ARF-GEF AtMIN7
(adenosine diphosphate ribosylation factor guanine
nucleotide exchange factor HopM interactor 7), for
degradation via the hosts' 26S proteasome (Nomura et al.,
2006, Nomura et al., 2011).

Organelles of the endomembrane

system are all part of the secretory pathway and consist of
the nuclear envelope, Endoplasmic reticulum, Golgi
apparatus, lysosomes, vacuoles, vesicles and cell
membranes.
Due to the fact that HopMl does not share any homology
with E3 ligases, it is highly possible that it serves as a
linker between AtMIN7 and the proteasome degradation
machinery of the host (Citovsky et al., 2009, Nomura et
al., 2006, Nomura et al., 2011). Brefeldin A, an inhibitor
of exocytosis, is capable of mimicking the effects of
HopMl, by inhibiting the GEF activity of the Sec7 protein
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family which AtMIN7 is a member of (Nomura et al., 2006),
thus supporting the fact that AtMIN7 plays a role in
defense component secretion (Thordal-Christensen, 2009).
In a study done by Nomura et al., in 2006, they were
able to show that a HopMl mutant containing amino acids
101-712 was able to partially restore ·the bacterial
multiplication and chlorotic symptoms of the conserved
effector locus mutant in Arabidopsis. They were also able
to show that mutants containing just amino acid 100-200 and
100-300 exerted a dominant negative effect on full length
HopMl function. There results hence lead to the conclusion
that the N-terminal 200 to 300 amino acids are able to
function as an independent domain in vivo, interfering with
the virulence function of the full length HopMl (Nomura et
al., 2006).
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CHAPTER 2

CREATION OF A YEAST MODEL SYSTEM TO EXPRESS PSEUDOMONAS
SYRINGAE PATHOVAR TOMATO DC300 EFFECTOR PROTEINS
Introduction

The majority of gram-negative bacterial pathogens make
use of the type III secretion system to inject their
effector proteins, thus causing disease in their animal or
plant hosts.

These effector proteins cause disease by

either attacking the host cells innate immune system, by
altering the vesicle trafficking pathway or by modifying
the cytoskeleton and membranes (Nomura et al., 2006). The
effector proteins are translocated directly across the cell
wall into the cytoplasm via the type III secretion system
injectisome, thus avoiding the basal resistance mechanism
of the cell.
Pseudomonas syringae is one of many gram-negative
phytopathogens that utilize this specific secretion system.
The Type III secretion system in Pseudomonas syringae is
encoded by the hypersensitive response and pathogenicity
(hrp) and the hypersensitive response and conserved (hrc)

genes of the Hrp pathogenicity islands (Munkvold et al.,
2008, Guo et al., 2009).

The effector proteins that are

injected into the host cell cause disease in susceptible
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plants mainly by suppressing the plant innate immunity. The
effectors injected into resistant plants are detected by
the plant resistant (R) proteins, thus activating the
effector triggered immunity (ETI), which triggers the
activation of the hypersensitive response (HR); a
programmed cell death (Guo et al., 2009, Munkvold et al.,
2008).
Depending on the phenotype displayed, the effector
proteins are either designated as Hrp dependent outer
proteins (Hops) or avirulence (Avr) proteins. All the
effector proteins that are secreted/translocated via the
type III secretion system display a Hop phenotype and some
also exhibit an Avr phenotype, depending on if the effector
or its. activity is recognized by the host cells resistance
(R) genes, which often results in the elicitation of the
hypersensitive response (Schechter et al., 2006).
There are many different strains of this
phytopathogen, with one being Pseudomonas syringae pathovar
tomato DC3000.

This pathogen causes bacterial speck in

tomatoes, the model system Arabidopsis thaliana and
Nicotiana benthamiana. This particular phytopathogen

translocates well over 40 different effector proteins into
its host cytoplasm, thus wrecking havoc to the hosts'
defense mechanism. The one reason behind this phytopathogen
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being well studied is that its entire genome has been
sequenced (Buell et al., 2003) and many of its effector
proteins are conserved among the different strains.
Of the 40 effector proteins that are
. injected into the
cytoplasm, one that is of interest to us is effector
protein HopMl. HopMl is conserved among all strains of
Pseudomonas syringae and it has been the focus of different

groups and here, we intend to present our results that have
proven to contradict published data. HopMl is a 712 amino
acid with no known domains (Nomura et al., 2006). It
localizes to the plant endomembrane as described by Nomura
et al., 2006. HopMl targets AtMIN7, a putative adenosine
diphosphate ribosylation factor-guanine nucleotide exchange
factor that is involved in intracellular .vesicle
trafficking in Arabidopsis thaliana. HopMl mediates the 26S
proteasome-dependent degradation of AtMIN7, a key player in
the initiation of vesicle trafficking (Nomura et al.,
2006).
The use of Saccharomyces cerevisiae as a model system
has been well established in accordance with studying the
effects of heterologously expressed proteins including
effector proteins. Due to yeast lacking the R protein
surveillance system that causes cell death during the
normal defense response in typical pathogen interactions,
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we have been able to utilize yeast in accordance with our
goals to study the virulence effect of the effectors on
yeast in the absence of the hypersensitive response. We
have been able to utilize the inducible GAL! promoter in
our efforts in light of research done �y Liu et al., 1992,
which demonstrated that a severe inhibition phenotype seen
in yeast under a GALl promoter is very small and more than
likely any inhibitory effect seen could be due to the
expression of the effectors (Munkvold et al., 2008).
In a paper published by Lesser et al., 2001, it is
shown that YopE, a GTPase activating protein, is cytotoxic
and disrupts the actin filaments in cells. Since then, many
groups have used yeast to examine the phenotypes and the
disruption of cellular processes by bacterial effector
proteins from both mammalian and plant pathogens.

With

this idea in mind, we are hoping that we would be able to
shed some light on the cellular pathways that are disrupted
in yeast due to the effects of HopMl.
In a· paper published by Munkvold et al., 2008, results
were presented showing that one of the effector proteins of
Pseudomonas syringae pv. tomato DC3000, HopMl has no effect
in yeast. In their study, Munkvold et al., 2008, looked at
the effect HopMl had on Saccharomyces cerevisiae at 30 °C.
Here we are presenting our data showing that HopMl has a
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phenotype in yeast and localizes to the mitochondria and
organelles or vesicles of the secretory pathway, in
accordance with results shown by Nomura et al., 2006, which
shows that HopMl localizes to the plant endomembrane when
expressed in Arabidopsis thaliana.
Materials and Methods

Media

LB (Luria-Bertani) media with appropriate antibiotic
was used for growth of bacterial culture, and has been
previously described (Sambrook et al., 1989).
Media for yeast growth such as YPD, YPG, S-ura, S-ura
leu (with and without glycerol), Sgal-ura, Sgal-ura-leu
(with and without glycerol), have been previously described
(Guthrie and Fink, 1991).
Plasmid Construction

Plasmids used in this study are listed in Table 1.
Plasmid pJG485 was constructed as described by Nejedlik et
al., 2004. Plasmid p416 GALl (Mumberg et al., 1994) that
contains the URAJ auxotrophic marker and an inducible
galactose promoter GALl was digested to liberate the GALl
vector and was ligated with the GATEWAY ™ fragment of pYES
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Dest52, forming pJG485. Plasmid pJG484 was constructed in a
similar way, except it contained the LEU2 auxotrophic
marker.
HopMl, HopAOl and HopAFl were PCR amplified from
Pseudomonas syringae pv. tomato DC3000 genomic DNA obtained
from ATCC using the N-terminal oligonucleotide attBl- HopMl
(5' - GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGATCAGTTCGCGGATCG- 3')
and the C-terminal oligonucleotide attB2- HopMl (5'
GGGGACCACTTTGTACAAGAAAGCTGGGTCACGCGGGTCAAGCAAGCCCT- 3'), N
terminal oligonucleotide attBl- HopAOl (5' GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGAATCCCCTGCAACCTATTC- 3')
and the C-terminal oligonucleotide attB2- HopAOl (5' GGGGACCACTTTGTACAAGAAAGCTGGGTCCTGTCCTCTAGGAATGGC- 3'), and
N-terminal oligonucleotide attBl- HopAFl (5' GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGGGCTATGTATTTCAA- 3') and
the C-terminal oligonucleotide attB2- HopAFl (5' GGGGACCACTTTGTACAAGAAAGCTGGGTCTTGTGCGACCAGATGTTTTATG- 3')
respectively. The resulting PCR fragments were combined
with pDONOR201 and allowed to recombine using the
Invitrogen GATEWAY™ BP reaction. The plasmid resulting for
the BP reaction, pJBl, pVRl0 and pVR12 contained HopMl,
HopAOl and HopAFl respectively with the flanking attLl and
attL2 sequences. The plasmids were sequenced to determine
sequence verification.
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The GATEWAY ™ LR reaction was used in order to create
plasmid pJB3, pVR20 and pVR21, which resulted from the
recombination of plasmid pJBl and pJG485, pVR18 with
pJG485, and pVR19 with pJG485 respectively. The GATEWAY™ LR
reaction was also used to created plasmid pJB2, which
resulted from the recombination of pJBl and pJG484.
Plasmids pJB2, pJB3, pVR20 and pVR21 all contained the V56xHis construct that would be expressed upon induction with
galactose.
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Plasmid
pDONOR201

Yeast

pDONOR221
CEN6 ARH4 LEU2 PGAL1 -(attR1 CmR ccdB
attR2)-V5-6xHis-CYC1.~CEN6 ARSH4 URA3 PGAL1 -( attRl CmR ccdB
pJG485
attR2)-VS-6xHis-CYClu=
pJBl
attLl hopMl attL2
CEN6 ARSH4 LEU2 PGALl-(attBl hopMl attB2)pJB2
V5-6xHis-CYCl.~-CEN6 ARSH4 URA3 PGAL 1 -(attBl hopMl attB2)pJB3
V5-6xHis-CYCl.~-attLl hopAOl attL2
pVR18
attLl hopAFl attL2
pVR19
CEN6 ARSH4 URA3 PGAL 1 -(attBl hopAOl
pVR20
attB2)-V5-6xHis-CYCl.~-CEN6 ARSH4 URA3 PGAL 1 -(attB1 hopAFl
pVR21
attB2)-VS-6xHis-CYCl.~Table 1. Plasmids used in this study.

pJG484

w
--.J

Bacteria
fl Kan R attPl ccdB
CmR attP2
fl KanR attPl ccdB
cmR attP2
fl bla

Reference
Invitrogen

fl bla

[ 4]

fl Kan R
fl bla

This study
This study

fl bla

This study

fl KanR
fl Kan R
fl bla

This study
This study
This study

fl bla

This study

Invitrogen
[ 5]

Yeast Strains

Strain

Chromosomal

JGY4

MATa lys2-801 his3-200 leu2-3, 112 ura3-52

JGY709

MATa/MATa ade2-101/ADE2 LYS2/lys2-801 his3200/his3-200 leu2-3, 112/leu2-3, 112 ura352/ura3-52

Table 2. Yeast strains used in this study.
Lithium Acetate Yeast Transformation

Each yeast strain was transformed as described (Gietz
and Schiestl, 1991). The night before transformation, the
different strains of yeast were inoculated into 25ml of
appropriate media and allowed to grow in a water bath at
30°C. The next day, the cultures were diluted back into
fresh media and once again were allowed to grow in a water
bath at ·30° c until it reached log phase. The cultures were
then centrifuged and resuspended in 5ml of dH 2 0. The
cultures were once again centrifuges and resuspended in
1.5ml of lX LiOAc and lX TE at pH 7.5, and incubated in a
spinning wheel incubator for 1 hour at 30° C. 20µ1 of heated
denatured sheared salmon sperm DNA and 5µ1 of transforming
DNA were added to the tubes and returned to the incubator
for 30 minutes. Next, 1.2ml of sterile 40%PEG, lX LiOAc and
lX TE at pH 7.5 were added to the tubes and returned to the
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incubator for 30 minutes.

The tubes were then heat shocked

for 15 minutes at 42°C. The cultures were then centrifuged
in a Labnet Spectrafuge 16M Microcentrifuge at 3000rpm and
washed with 1ml sterile lX TE at pH 7.5. The cultures were
plated onto appropriate selective dropout media and allowed
to grow at room temperature for 5 days.
Western Blotting

Western Blotting was performed as previously described
by Nejedlik et al., 2004. Yeast strains were grown to about
mid-log phase in SD-Ura minimal media with raffinose as the
sole carbon source. At time point zero, the cells were
induced with Galactose to a final concentration of 2%.
Aliquots were taken at time point 1, 3, 24 and 48, and the
extracts were prepared as described by Kahana et al., 1998.
l00µg of the extracts from each time point were separated on
an 8% SDS polyacrylamide gel (Laemmli, 1970) and
transferred to a PVDF membrane at 30V overnight (Sambrook
et al., 1989). To achieve western immunoblotting, the
membrane was blocked with 0.2% I-Block (Tropix) in PBS.
This was followed by the application of anti-VS antibody
(Invitrogen) at 1:200 dilution. Visualization of the HopMl
VS protein was accomplished using the ECL Western Blotting
Analysis Kit from Amersham.
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Serial Dilution Replica Plating
Serial dilution replica plating was performed as
described below. Transformants of HopMl and the control
vector pJG485 were grown overnight in S-ura-leu and S�ura
media containing 2% raffinose at 21° C. The next day, the
transformants were plated onto S-ura-leu, S-ura, Sgal-ura,
Sgal-ura-leu and YPD solid media via replica plating. The
plates were maintained at room temperature and allowed to
grow for about 5 days.
Titer Assay
A titer assay was performed as previously described by
Nejedlik et al., 2004. The respective expression vector
containing HopMl, pJB3 and an empty vector pJG485 as a
control were first transformed into JGY4 haploid strain of
yeast. These transformants were then grown up in S-ura
medium respectively with 2% raffinose as the carbon source
and allowed to grow overnight at 21° C. The next day, the
cultures were diluted back into fresh medium with
appropriate amount of raffinose and allowed to grow to mid
log phase, upon which HopMl expression was induced via the
addition of 2% galactose.

1ml samples were taken at each

time point after the floculence of the cultures were
measured and recorded.

The samples were then sonicated for
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10s at 3.5W using a Fisher Model 50 Sonic Dismembrator.

A

10 fold serial dilution was performed on each sample and
100µ1 of each dilution was plated onto SD-ura media. The
plates were left at room temperature to grow for about 1
week, after which the number of colony forming units per ml
was determined.
Hop Immunofluorescence

Irnrnunofluorescence was performed as previously
described by Geiser et al., 1997, Hoyt et al., 1997 and
Kahana et al., 1998).

Aliquots of 100µ1 of sonicated

samples of cells from each time point were fixed in 3.7%
formaldehyde at room temperature for 2 hours. The samples
were digested with S0µg/ml of Zymolyase 100T, and then
dissolved in 1.2M Sorbitol, 25rnM �-mercaptoethanol, and
l00rnM KPO 4 for 1 hour at 30° C to dissolve the cell wall. The
samples were then washed with 0.04%PBS-BSA and applied to
polylysine-coated slides. Ideally, to visualize the Hops,
mouse monoclonal anti-VS antibody was diluted 1:800 in
0.04%PBS-BSA and allowed to incubate for 2 hours at room
temperature. The samples were once again washed 3 times
with 0.04%PBS-BSA and the goat anti-mouse CY2 (1:100) was
applied to the samples and allowed to incubate for 2 hours
at room temperature. DAPI (4', 6- Diamidino-2-phenylindole
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dihydrochloride from Sigma-Aldrich) was used to stain the
DNA and was applied to the samples for 3 minutes at room
temperature. Mounting solution was prepared following the
protocol outlined by Pringle et al., 1991. The slides were
observed using a Leica DM5500B microscope with a Q-Imaging
Retiga Exi 1394 fast camera.
Mitochondrial Staining

Fluorescent staining of mitochondria were performed
using Mitotracker Red CMXRos (Invitrogen).

Cultures were

grown in appropriate media and conditions for at least two
generations in log-phase.

Mitotracker Red CMXRos (lmM in

DMSO) was added to the culture 30 minutes prior to addition
of galactose (t = 0 hr.) to a final concentration of 0.4uM.
Cells were prepared as above for immunofluorescence and
imaged with a Leica TX2 filter set.
Yeast Cellular Fractionation

Yeast Cellular Fractionation was performed as
described by Reider and Emr, 2000, Zinser and Daum, 1995
and Wiederhold et al., 2010, with modifications as listed
below. Yeast strains were grown overnight in 100ml YPD. The
overnight cultures were then harvested and centrifuged in a
Sorvall RC SB Plus centrifuge using a SS-34 rotor for 5
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minutes at 500g. The resulting cell pellet was washed with
l00rnM Sodium Azide and 50rnM Tris-HCl pH 7.5 and centrifuged
again. The cell pellet was incubated with l00rnM EDTA, 0.5%
2-mercaptoethanol and l0rnM Tris-HCl pH7.5 at 30°C for 20
minutes. After 20 minutes, a cell pellet was obtained via
centrifugation for 5 minutes at 500g, ·after which it was
resuspended in S Buffer (1.2M Sorbitol, 0.5rnM MgC1 2 and 40rnM
HEPES pH7.5). The cells were then converted to spheroplasts
with the addition of 50U/OD600 Zymolyase 100T and allowed
to incubate for 90 minutes at 30° C. The spheroplasts are
washed once in S Buffer and suspended in Lysis Buffer (0.2M
Sorbitol, lrnM EDTA, 50rnM Tris-HCl pH7.5). A Dounce
Homogenizer is then used to lyse the spheroplasts. A sample
is collected from the cell lysate and labeled Sample 1. The
remaining cell lysate is centrifuged in a Beckman
Ultracentrifuge Optima XL-l00K using a swing bucket rotor
(Beckman SW 55Ti) for 5000g for 10 minutes at 4°C. The
resulting pellet is labeled P5000 and the resulting
supernatant is labeled S5000. The supernatant is further
centrifuged at 20,000g for 1 hour to yield the P20,000
pellet and the S20,000 supernatant. The S20,000 supernatant
is further centrifuged for 1 hour at 300,000g to yield the
P300,000 pellet and the S300,000 supernatant.
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Sucrose Density Gradient Centrifugation

Density sucrose gradients were used to isolate
different organelles. A sucrose step gradient using 1.5M
Sucrose and 1.2M Sucrose Solutions was prepared using a
peristaltic pump to layer the 1.2M Sucrose Solution on top
of the 1.5M Sucrose Solution. After the gradients were set
up, 200µ1 of the samples resulting from the yeast
fractionation protocol were layered over the top of the
gradients. The gradients were centrifuged in a Beckman
Ultracentrifuge Optima XL-l00K using a swing bucket
(Beckman SW 55Ti) at 85,000g for 1 hour. Once the gradients
were centrifuged, they were carefully removed from the
swing buckets and the visible bands present in the
different layers of the step gradients were collected and
analyzed via Western Blot.
Creation of a Petite Yeast Strain

A petite yeast strain was created as described by
Guthrie and Fink, 1991 with modification. Yeast strain JGY4
was grown to saturation in minimal medium containing 2%
glucose and 25µg/ml Ethidium Bromide. A second culture is
started from the first culture and allowed to grow to
saturation. From here, a small amount of culture is plated
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onto YPD and essentially every colony that grows will be
rho 0 •
Results

Construction of a Pseudomonas syringae Effector Model
System

There are significant similarities that exist among
Saccharomyces cerevisiae proteins and mammalian signal
transduction pathways, cell cycle pathways and the proteins
involved in the construction and modifying of the
cytoskeleton (Nejedlik et al., 2004).
To be able to test our model system, we created yeast
plasmids pJB2 and pJB3, which contains Pseudomonas syringae
pv. tomato DC3000 hopMl that is under the control of GALl,
an inducible yeast promoter, and each plasmid contained
either the URAJ or LEU2 auxotrophic marker. Fused to the 3'
end of hopMl is DNA that encodes for the VS epitope and six
copies of the histidine affinity purification tag. We also
created plasmid pVR20 and pVR21 that contains Pseudomonas
syringae pv. tomato DC3000 hopAOl and hopAFl respectively.
We used pJG484 and pJG485, which were lacking hopMl but
containing all other plasmid sequences as control plasmids.
All plasmids were transformed into the wild-type yeast
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strain JGY4 and selected on media lacking uracil and
leucine respectively in order to isolate a strain
containing each plasmid.
HopMl is Produced in Yeast

To determine if the model system was working as
expected and expressing the effector protein, a western
blot was performed. The yeast strain JGY4 containing
plasmid pJB2 and pJB3 was grown to mid-log phase in minimal
selective media. Effector protein expression was induced
and aliquots were taken at numerous time points and
processed. As shown in Figure 1, you begin to s�e the
expression of HopMl beginning at hour 3 after induction and
minimal expression is observed at hour 24.
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Figure 1. HopMl is produced in yeast. Yeast strain JGY4
containing pJB2 and pJB3 was induced with galactose for 48
hours. Aliquots were taken and protein extracts prepared.
The level of HopMl-VS in un-induced and induced cultures
were determined by immunoblotting. Molecular weight marker
is shown. Arrow indicates the expected molecular weight
(75kDa) of HopMl protein.
Expression of Pseudomonas syringae Effectors in Yeast

In order to determine if the expression of our
numerous plasmids are capable of disrupting the growth of
yeast, we compared the growth of the yeast strains
containing the different plasmids to one that contained the
control plasmid. Yeast strains containing the different
plasmids were replica plated onto SD-ura, Sgal-ura, SD-ura
leu and Sgal-ura-leu media and allowed to grow at 21 ° C for 4
days. As shown in figure 2,. the yeast strain containing the
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control plasmid and HopAOl and HopAFl were able to grow at
all conditions and produced colonies across all dilutions.
As shown in figure 3, the strain containing HopMl however,
was not able to grow on the Sgal-ura-leu plates at 21° C.

WT
HopM1
HopA01
HopAF1
Sgal-ura

Sd-ura

Figure 2. HopAOl and HopAFl are not lethal. Yeast strain
JGY4 containing control (pJG485), HopMl (pJB3), HopAOl
(pVR20) and HopAFl (pVR21) were replica plated onto SD (SD
ura) or Sgal (Sgal-ura) medium and incubated at 21° C for 4
days. Each spot of cells is a 40-fold dilution of the cells
in the previous spot.

WT
HopM1
HopM1 (0) -:.....;.;....,;..__,.'""'-.....

Sd-ura-leu

Sgal-ura-leu

Figure 3. HopMl is lethal in yeast. Yeast strain JGY4
containing control (pJG4845), HopMl (pJB2 and pJB3),
plasmids were replica plated onto SD (SD-ura-leu) or Sgal
(Sgal-ura-leu) medium and incubated at 21° C for 4 days. Each
spot of cells is a 40-fold dilution of the cells in the
previous spot.
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While working on the expression of these three
effector proteins, Munkvold et al.; 2008, published results
on similar work done in yeast with effectors. Their results
show that HopMl is not inhibitory to yeast growth at 30 ° C,
but in our hands, we have been able to show that HopMl is
inhibitory to yeast growth at 21° C. With these results in
hand, we set out to look at the effects of HopMl more
extensively.
Titer Assay Of HopMl

To determine if HopMl expression is cytotoxic or
cytostatic to yeast, we measured the strain looking at the
number of cells able to grow on solid dextrose media after
being removed from galactose induction. The yeast strain
containing the control plasmid increased steadily over the
course of the 48 hour experiment. The number of cells able
to grow in the yeast strain expressing HopMl slowly began
to decrease 7 hours after galactose induction. At hour 24,
when the maximum amount of HopMl was observed by western
blot analysis, there were about 91% of viable cells and
this number continued to decrease up to hour 48 with only
37.5% viable cells remaining. Refer to Figure 4 for graph.
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Figure 4. Examination of cell viability of yeast strain
containing HopMl. Yeast strain JGY4 containing HopMl (pJB2
and pJB3) or control plasmid (pJG484 and pJG485) were grown
in selective medium containing 2% raffinose. 2% galactose
was added to the medium at the zero time point to induce
HopMl production. 1ml aliquots were taken at each time
point, sonicated and serially diluted onto SD-ura-leu
plates. Each curve is a representative of three different
trials for each strain.
Expression of HopMl is Lethal to Yeast at 21 ° C

In order to understand the results that were seen by
Munkvold et al., 2008, we wanted to examine the effect of
HopMl expression in yeast. This was done by comparing
strains containing the HopMl plasmids with a strain
containing the control plasmids. The strains were replica
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plated onto Sgal-ura-leu medium and allowed to grow at 21 ° C,
30° C and 37 ° C for 4 days. Figure 5 shows the results of this
replica plating. The strain containing the control plasmid
grew as expected at all temperatures, producing colonies at
all dilutions and on all selection media. The strain
containing the HopMl plasmid however, �id not grow on the
Sgal-ura-leu plates at 21 ° c, but was able to grow on the
Sgal-ura-leu plates at 30° C and 37 ° C. Our results are
consistent with the results presented by Munkvold et al.,
2008, at 30° C and 37° C, in which they showed that HopMl was
able to grow on the Sgal-ura-leu selection media at 30°C.
Our results show an unappreciated finding in that
expression of HopMl in yeast kills at 21 ° C but not at 30° C
and 37° C.
We examined the expression of HopMl in haploid (JGY4)
and diploid (JGY709) yeast strains. Two HopMl expressing
plasmids (pJB2 and pJB3) were transformed into the
respective strains, replica plated onto Sd-ura-leu and
Sgal-ura-leu medium and allowed to grow at 21 °C for 4 days.
Figure 6 shows the results from this replica plating. The
strain containing the control plasmids grew as expected,
producing colonies across all dilutions. The diploid yeast
strain containing the HopMl plasmids, were able to grow on
both Sd-ura-leu and Sgal-ura-leu, as compared to the
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haploid yeast strain that was able to grow on only Sd-ura
leu as shown earlier. We do not know why the diploid yeast
strain expressing both HopMl plasmids is able to grow but
it could possibly be due to the difference in growth or
polarity of the diploid.
To further examine the expression· pattern of HopMl at
these different temperatures, we examined the protein
expression of HopMl at multiple growth temperatures.

21°c

3o0c

WT

37°c
Sgal-ura-leu

HopM1
WT

Sd-ura-leu

HopM1
Figure 5. HopMl is lethal in yeast at 21 ° C. Yeast strain
JGY4 containing control (pJG4845 and pJG484) and HopMl
(pJB2 and pJB3) plasmids were replica plated onto SD (SD
ura-leu) or Sgal (Sgal-ura-leu) medium and incubated at
21 ° c, 30 ° C and 37 ° C for 4 days. Each spot of cells is a 40fold dilution of the cells in the previous spot.
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Figure 6. Effects of HopMl in haploid and diploid yeast.
Yeast strain JGY4 (H) and JGY709 (D) containing control
(pJG484 and pJG485) and HopMl (pJB2 and pJB3) plasmids were
replica plated onto SD (SD-ura-leu) or Sgal (Sgal-ura-leu)
medium and incubated at 21 ° C for 4 days. Each spot of cells
is a 40-fold dilution of cells in the previous spot.
Expression of HopMl at 21 ° c, 30 ° C and 37 ° C

To further understand the results seen from serial
dilution at the different temperatures (figure 5), we
performed western blot analysis, looking at the protein
expression of HopMl across these different temperatures.
Figure 7 shows the results obtained from the western blot.
We begin to slowly see production of HopMl at 30 ° C beginning
at hour 1 with maximal expression at hour 3 and HopMl is
slowly produced at 37° C beginning at hour 1 with maximal
expression at hour 24. However, on closer inspection, we
see that there are degradation products for HopMl at 30 ° C
and 37° C and that the bands appear a little lower than the
expected size of 75kDa. These degradation products could
possibly be the reason why HopMl is able to grow on the
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Sgal-ura-leu plates as seen with the serial dilution at 30° C
and 37° C. Another possibility could be that the protein is
unstable at these high temperatures. Literature also
indicates that the effector proteins from Pseudomonas
syringae pv. tomato do not elicit an effect in tomato
plants at temperatures higher than 25° C but instead prefer
cool and moist climates to be able to elicit an effect
(Preston, 2000)
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Figure 7. HopMl is produced in yeast at all three
temperatures. Yeast strain JGY4 that was co-transformed
with plasmid pJB2 and pJB3 was induced with galactose for
48 hours. Aliquots of the strain were taken at resp�ctive
time points and the extracts were prepared.
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Localization of HopMl

We next wanted to look at the cellular localization of
HopMl. Strains containing the control plasmid and HopMl
were induced with galactose and prepared for indirect
immunofluorescence. At 3 hours after induction, we observed
that HopMl localized to punctate like structures in the
cytoplasm of the cell as shown in Figure 8. There was no
difference in observation at hour 24, which was when the
maximum expression of HopMl was observed in western blot
analysis, or even at hour 48 after induction.
We utilized the stain Mitotracker Red (Invitrogen) to
observe the localization of mitochondria in our strain
expressing HopMl. Figure 8 shows the mitochondria stained
as red thin tubules in the cell. Overlap images (Figure 9)
were prepared to help determine if there was any co
localization between HopMl and mitochondria. On observing
the structures closely, we conclude that there is some
overlap between the punctate structures that HopMl
localizes to and the mitochondria.
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HopMl
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Figure 8. Localization of HopMl in yeast. Yeast strain JGY4
containing HopMl (pJB3) or control plasmid (pJG485) was
grown in selective media containing 2% raffinose. HopMl was
induced after time point zero with the addition of 2%
galactose. Aliquots were taken at each time point and fixed
with 3.7% formaldehyde for 2 hours. Immunofluorescence was
used to visualize the VS epitope, Mitotracker Red and DAPI
to visualize mitochondria and dna respectively.

HrO

Hr1

Hr24

Figure 9. Overlay of yeast expressing HopMl. Yeast strain
JGY4 containing HopMl (pJB3) was grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope, Mitotracker Red and DAPI staining to visualize the
mitochondria and dna respectively.
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Cellular Fractionation of Yeast Strains
We moved to performing cellular fractionation and
sucrose density gradient centrifugation of yeast strains
containing the HopMl or control plasmids to further
determine HopMl localization. Fractions resulting from the
sucrose density gradient centrifugation were separated
using an 8% SDS polyacrylamide gel. The resulting gel was
transferred to a PVDF membrane and probed with the antibody
for the VS epitope. Figures 11 and 12 show the results of
the western blots for the yeast strain containing the HopMl
plasmids and control plasmids. On looking at Figure 11, we
see that HopMl (75kDa) appears in the lanes indicated as
Pl, S1, P2, S2, P3 and P2t. In each of these fractions, we
expect to see the presence of HopMl (75kDa) as these
fractions contain a combination of plasma membrane
vesicles, mitochondria and secretory vesicles. The bands
that appear towards the bottom of each lane are indication
of non-specific binding and this is confirmed by the
results as shown in figure 12 that shows the western blot
analysis of the yeast strain containing the control vector.
Figure 10 shows a schematic diagram of the cellular
fractionations and sucrose density gradient centrifugation
protocol.
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Figure 10. Diagram of cell fractionation and sucrose
density centrifugation protocol.
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Figure 11. Western Blot Analysis of cellular fractionation
and sucrose gradient density centrifugation of yeast strain
containing pJB2 and pJB3. The levels of HopM1-V5 in the
fractions resulting from the cellular fractionation
(labeled CL, Pl, S1, P2, S2, P3 and S3) and fractions from
sucrose gradient density centrifugation (labeled P2t and
p2b) were determined by immunoblotting. Molecular weight
marker is shown. Arrow indicates the expected molecular
weight (75kDa) of HopMl protein.
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Figure 12. Western Blot analysis of cellular fractionation
and sucrose density gradient centrifugation of yeast strain
containing control plasmids. The levels of HopM1-V5 in the
fractions resulting from the cellular fractionation
(labeled CL, Pl, Sl, P2, S2, P3 and S3) were determined by
immunoblotting. Molecular weight marker is shown. Arrow
indicates the expected molecular weight (75kDa) of HopMl
protein.

Effect of HopMl is Not Affected in a Yeast Strain
Lacking the Mitochondria

In order to determine if the expression of a petite
yeast strain containing either HopMl or the empty vector
changed, we performed serial dilution replica plating of
the petite yeast strains before inducing with 2% galactose
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and 24 hours after induction onto YPD, Sd-ura-leu, Sgal
ura-leu, Sglycerol-ura-leu and Sglycerol-ura-leu
supplemented with galactose, and allowed the plates to
incubate at 21°C for 1 week. We also performed serial
dilution replica plating of the wild type yeast strain
(JGY4) containing HopMl or the empty vector under the same
conditions onto YPD, Sd-ura-leu, Sgal-ura-leu, Sgylcerol
ura-leu and Sglycerol-ura-leu supplemented with galactose.
Figure 13 and 14 show the results of the replica
plating. The petite yeast strain (yeast strain lacking
mitochondria - see figure 13) containing the HopMl plasmids
and the control plasmids were not able to grow on the media
containing glycerol. This is due ·to the fact that yeast
strains lacking mitochondria are not able to grow on
respiratory media such as glycerol. Figure 14 shows the
results for the wild type yeast strain (JGY4). We are able
to see growth on the media containing glycerol.

From both

these results, we are able to determine that despite
removing the mitochondria, we are still able to see the
lethal effects of HopMl.
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Figure 13. Effects of HopMl on yeast strain lacking
mitochondria. Yeast lacking mitochondria show a lethal
phenotype. Petite yeast strain containing control (pJG484
and pJG485) and HopMl (pJB2 and pJB3) plasmids were replica
plated onto SD (SD-ura-leu), Sgal (Sgal-ura-leu) and
Sglycerol (Sgly-ura-leu) medium and incubated at 21° C for 4
days. Each spot of cells is a 40-fold dilution of cells in
the previous spot.
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Figure 14. Mitochondria are still functional in yeast
strain expressing HopMl. Yeast strain (JGY4) containing
control (pJG484 and pJG485) and HopMl (pJB2 and pJB3)
plasmids were replica plated onto SD (SD-ura-leu), Sgal
(Sgal-ura-leu) and Sglycerol (Sgly-ura-leu) medium and
incubated at 21°C for 4 days. Each spot of cells is a 40fold dilution of cells in the previous spot.

Discussion
We were able to successfully create a Pseudomonas

syringae effector model system in Saccharomyces cerevisiae
to study the effects of the effector proteins from

Pseudomonas syringae pv. tomato DC3000. In order to be able
to determine if HopMl showed a phenotype in yeast, we
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created the yeast plasmids pJB2 and pJB3, which contain
hopMl under the control of GALl with either the LEU2 or
URA3 autotrophic marker for selection. Plasmids were
transformed into yeast strain JGY4 and selected on media
lacking uracil and leucine to isolate the yeast strain
containing both plasmids. Western blot· analysis was
performed to show that our model was in fact working as
expected. Results from the Western blot show that HopMl
expression begins at hour 3 with maximal expression at hour
24, at the expected molecular weight of 75kDa.
We have been able to show that HopMl is able to
inhibit the growth of yeast on solid media at 21 ° C. These
results contradict the results that were published by
Munkvold et al., (2008), which states that HopMl is not
lethal to the yeast on solid media at 30° C. The discrepancy
in these results are due to the fact that we examined the
effect HopMl had on yeast at numerous temperatures and
found that at 21 ° C, HopMl was lethal to the yeast. On
looking at the expression of HopMl at 30° C and 37 ° C, we see
that HopMl is expressed at both these temperatures but also
observe degradation bands at these temperatures. These
degradation bands could point to the reason behind why
HopMl is able to grow on Sgal-ura-leu plates as seen with
the serial dilution at 30°C and 37 ° C. Another reason could
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be the protein is unstable at these higher temperatures.
According to literature, the bacterium Pseudomonas syringae
pv. tomato DC3000 elicits an effect in its host plants at
cool moist temperatures between 18°C and 25 °C (Preston,
2000) and at temperatures above this; only a minimal effect
if any is seen. This is what led us to choosing 21°C as one
of our parameters.
Next, we wanted to determine if HopMl had a cytotoxic
or cytostatic effect and this was done by looking at the
number of viable cells after removal from the inducer. Our
results showed that HopMl does not have an outright
cytotoxic effect unlike YopO (Nejedlik et al., 2004).
Instead, HopMl proved to be unique. Even at the time point
that corresponds to the maximal expression of HopMl (from
western blot analysis), there were about 91% viable cells
and at hour 48, there were about 37.5% viable cells. This
hints at the possibility that HopMl has a cytostatic
effect; where the cells have slowed down in cycling through
the growth cycle, or they have stopped dividing altogether
but are able to grow once removed from the presence of the
inducer.
Upon looking at the localization of HopMl, we were
able to observe HopMl localizing to punctate structures in
the cytoplasm of the cell, with no obvious localization to
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the nucleus as shown by DAPI staining beginning at hour 3
after induction. We utilized the stain Mitotracker Red to
help determine if HopMl was localizing to the mitochondria.
We observed that HopMl not only localized to the
mitochondria but to punctate structures in the cytoplasm.
In yeast, organelles such as the mitodhondria, endoplasmic
reticulum, golgi apparatus, endosomes and vesicles, all
membrane bound organelles, appear as punctate structures
when viewed under microscopy. Actin localization was also
examined and we saw no obvious actin disruption (results
not shown). We moved to performing cellular fractionation
and separation of fractions on sucrose density gradients to
determine the identity of these organelles.
Results from the western blot analysis of the
fractions from cellular fractionations and sucrose density
gradients all point to HopMl co-sedimenting to the
mitochondria and organelles or vesicles of the secretory
pathway; as indicated by the presence of HopMl in the
fractions containing mitochondria, plasma membranes,
endoplasmic reticulum and golgi.
The result that we obtained from HopMl localization is
similar to results obtained by Nomura et al., 2006. They
looked at the expression of HopMl in Arabidopsis cell
fractions of the total membrane, soluble fraction, plasma
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membrane and endomembrane and discovered that HopMl is
found in the endomembrane fraction and not the rest. This
would be consistent with the fact that the endomembrane
system is comprised of the endoplasmic reticulum, golgi
apparatus, lysosomes, vacuoles, vesicles and cell
membranes.
We obtained interesting results when trying to
determine if the expression of HopMl varied in the
different strains of yeast. When expressed in the haploid
yeast strain JGY4, HopMl produced a lethal effect, and this
is shown with the yeast strain containing HopMl not being
able to grow on Sgal-ura-leu plates. When HopMl was
expressed in the diploid strain of yeast (JGY709), the
cells were able to grow on both Sd-ura-leu and Sgal-ura-leu
plates.

This was surprising, as we had expected that the

diploid strain would have also produced the lethal effect
as seen in the haploid strain.
To further understand if HopMl localization was
affected by mitochondria, we proceeded to create a petite
yeast strain (rho-zero) that lacked mitochondrial DNA. Rho
zero yeast strains are able to grow slowly on media
containing glucose but are not able to grow on respiratory
media such as media glycerol or ethanol. From looking at
the resuits presented, we are able to conclude that the
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effects of HopMl are not affected by the absence of
mitochondria. As presented in an earlier section, we have
shown that HopMl localizes to the mitochondria (see figure
8, 9 and 11) but binding to the mitochondria alone is not
sufficient for the lethal effects of HopMl as observed from
figure 13. Rather, HopMl is affecting �he mitochondria and
the secretory pathway to cause its effect in yeast.
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CHAPTER 3
ISOLATION OF SPONTANEOUS SUPPRESSORS OF HOPMl IMPOSED
LETHALITY
Introduction

Spontaneous suppressors are an invaluable tool for
elucidating the role/identity of unknown cellular targets
(Prelich G, 1999). Since first being described by
Sturtevant in 1920 when looking at gynandromorphism and the
exception displayed by vermilion eye color in Drosophilla
melanogaster (Sturtevant, A.H., 1920), suppressors have
been used to study genetic pathways (Prelich G, 1999).
As presented in an earlier chapter (see chapter 2),
HopMl has a lethal phenotype when expressed in yeast. The
goal with creating spontaneous suppressors is to be able to
identify cellular targets of HopMl and the gene(s) and
their protein products that are required for the imposed
lethality.

Using this screen, we identified 19 spontaneous

revertants of HopMl lethal -phenotype.

We were also able to

further characterize these suppressors by growth rates,
protein expression levels of HopMl, localization and
ability to sporulate.
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Materials and Methods
Media

Media for yeast growth such as YPD, SD-ura, SD-ura
leu, Sgal-ura, and Sgal-ura-leu have been previously
described (Guthrie and Fink, 1991). Sporulation media was
made as described by Guthrie and Fink, 1991.
Lithium Acetate Yeast Transformation

Yeast strains were transformed as described (Gietz and
Schiestl, 1991).
Creation of Suppressor Strains

Plasmids pJB2 (HopMl LEU2) and pJB3 (HopMl URA3) were
co-transformed into haploid yeast strain JGY4 (see table
3). Two plasmids were used in order to determine that the
mutation we generated and isolated occurred in the yeast
genome and not in the plasmids. If for example the mutation
were to occur in the GALl promoter of one plasmid resulting
in no expression of HopMl, the other plasmid would still
function normally and allow us to proceed with our designed
screen. Independent transformants that were isolated were
grown overnight in Sraffinose-ura-leu media, with raffinose
being used as the sole carbon source to help prime the
yeast and prepare them for transitioning into galactose.
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The overnight cultures were induced with galactose to turn
on expression of HopMl and 24 hours following induction, 10 7
cells were plated onto Sgal-ura-leu. The plates were
allowed to grow at 21° c for 5 days.
Sporulation

Suppressor strains were grown in 5ml of sporulation
media with rotation at room temperature for 5 days after
which 100µ1 samples were collected from each strain and
digested with 3µ1 Zymolyase 20T for 10-20 minutes.
Treatment with Zymolyase allows for the weakening of the
spore ascus by the digestion of �1-3 glucanase, thus
enabling ease of separation of individual spores. 20µ1 of
the digested sample is then plated down the centre of a YPD
plate and dissected under a Nikon Eclipse E400 Microscope
using a micromanipulator. Dissection was carried out as
described by Guthrie and Fink, 1991. The dissected plates
were allowed to sit at room temperature for 4 days to allow
for growth of spores, after which both HopMl plasmids were
transformed back in and transformants were screened to look
for the ability to survive HopMl imposed lethality. Once
the spores containing the suppressor gene were identified,
they were mated with yeast strain JGY3 that is of mating
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type a (See Table 3), and the whole process wa$ repeated to
obtain heterozygous diploid suppressors.
Strain

Chromosome

JGY3

MATa ade2-101 his3-200 leu2-3, 112 ura3-52

JGY4

MATCX lys2-801 his3-200 leu2-3, 112 ura3-52

Table 3. Yeast strains used.
Titer Assay

A titer assay of all haploid suppressors was performed
as previously described in chapter 2.
Western Blotting

Western Blotting of all haploid suppressors was
performed as previously described in chapter 2.
Hop Immunofluorescence

Immunofluorescence was performed as previously
described in chapter 2.
High Molecular Weight Yeast DNA

High Molecular Weight Yeast DNA was prepared as
described by Guthrie and Fink, 1991 with modifications.
Essentially, yeast strains were grown for 2 days in a liter
of YPD media at 21 ° C. Once cells had grown to 2xl0 8 cells/ml,
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the cultures were harvested and centrifuged in a Sorvall RC
SB Plus centrifuge using a SS-34 rotor at 4° C for 10 minutes
at 500g. The resulting pellet was then washed once with
1/Sth volume of ice-cold 50mM EDTA and resuspended in 10ml
of Tris-HCl pH8.0 with 2% v/v 2-mercaptoethanol and allowed
to incubate for 15 minutes at room temperature. The
resuspended cells were then centrifuged again. The
supernatant was poured off and the pellet was resuspended
in the remaining supernatant and layered over liquid
nitrogen drop by drop in a cooled pestle and mortar. The
droplets are then ground up in the pestle and mortar until
it forms a white powder. Liquid nitrogen is added as needed
to keep powder cold. Once this is accomplished, the powder
is resuspended in 1/200th volume of Lysis Buffer (0.lM Tris
HCl pH8.0, 0.lM EDTA, 0.15M NaCl and 2% 2 mercaptoethanol)
to form spheroplasts. The spheroplasts are lysed further by
3 fold dilution into Lysis Buffer made 4% v/v with Sarkosyl
and incubated at 37°C for 20 minutes. Following the 20
minute incubation, equal volume of Lysis Buffer (0.lM Tris
HCl pH8.0 and 4% Sarkosyl) is added and incubated at 70° C
for 15 minutes. DNAse-free RNase (0.lmg/ml) is added to the
culture and allowed to incubate at 37°C for 1 hour after
which Proteinase K (Sigma) is added to a final
concentration of 1.33mg/ml in two aliquots at hourly
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intervals and allowed to continue incubating at 37° C for a
total of 2 hours. After the incubation, the cells are
incubated at 70°C for 15 minutes. Phenol/Chloroform/Isoamyl
alcohol 25:25:1 v/v is added and allowed to rock gently at
room temperature until a white emulsion forms (20 minutes).
The phases are then separated by centrifugation at 20,000g
at room temperature for 10 minutes in a bench top Eppendorf
5810R Centrifuge. The aqueous supernatant is removed to a
new tube and incubated at 45° C to remove all traces of
chloroform.

To further isolate the high molecular weight

DNA, 10ml of the sample is layered on 24ml preparative step
sucrose gradients. The gradients are centrifuged in a
Beckman Ultracentrifuge Optima XL-l00K using a swing bucket
(Beckman SW 28) at 33,000g for 17 hours at 4° C. 1ml samples
are collected from the top of the gradient using a wide
bore pipette. Small aliquots of the samples are then
analyzed on a 1% Agarose gel. Samples containing the
correct band size are pooled and dialyzed against 0.15M
NaCl, l0mM Tris-HCl pH 8.0 and lmM EDTA.
Size Fractionation of Partially Digested Genomic DNA

Genomic DNA that was obtained after dialyzing was
partially digested as described by Maniatis et al., 1982.
Briefly, aliquots of DNA were digested using a 10-fold
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dilution of the restriction enzyme Sau3A to determine the
ideal enzyme concentration that would yield maximum
results. The ideal enzyme concentration was determined to
be 1:5000 dilution per l0ng of DNA. The reaction was then
scaled up to obtain a good yield of partially digested
genomic DNA.
Dephosphorylation of Vector

The vector pRS313 (see table 4) was dephosphorylated
as described in Guthrie and Fink, 1991. Shrimp Alkaline
Phosphatase was used to remove the 5' Phosphates from the
vector DNA.

Plasmid

pRS313

Yeast

CEN6 ARSH4 HIS3

Bacteria
fl bla

Table 4. Plasmid used for cloning.

Results

Creation of Suppressors

Yeast strain JGY4 (Table 3) was transformed with two
HopMl expressing plasmids (pJB2 and pJB3). Plasmid pJB2 and
pJB3 contain the LEU2 and URA3 auxotrophic marker
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respectively. We began our screen with 30 inde�endent
populations. 30 different populations were started from 30
different colonies in different tubes. The yeast strain
containing both plasmids were plated onto Sgal-ura-leu
media at a concentration of 10 7 cells, which is the normal
mutation rate of the auxotrophic marker Uracil (Geiser et
al., 1993), and allowed to grow at room temperature for 5
days. Under normal conditions, when the yeast strain
containing both HopMl plasmids are plated onto Sgal-ura-leu
media, growth of yeast strains on this media would be
inhibited due to the lethality of HopMl.
Twenty of the plates produced colonies and the
remaining ten were discarded. Three colonies from each of
the 20 plates were selected for further characterization.
Each potential suppressor was assayed to determine if it
was able to lose both plasmids. This step was crucial to
make sure that neither plasmid had integrated into the
genome. Thirty of the sixty potential suppressor strains
were able to lose both plasmids. Plasmids pJB2 and pJB3
were transformed back in to the 30 potential suppressors
and allowed to grow at room temperature for 5 days. All
potential suppressor strains were assayed for ability to
grow when HopMl was expressed from the GALl promoter.
Nineteen suppressor strains were obtained based on their
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robust growth on Sgal-ura-leu media. The 19 strains contain
14 that are independent and 5 that may be siblings. These ·
suppressors were named SupMl 1-19. See table 5.
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Suppressor

Original Name

Ability to Sporulate

Western Blot Degradation

SupMl-1

1B2

No

Yes

Yes

No

SupMl-2

3Al

SupMl-4

7A2

Yes

Yes

SupMl-6

13Al

Yes

No

SupMl-8

14A2

SupMl-3
SupMl-5

SupMl-7
SupMl-9

--..J
CX)

SupMl-10

3A2

8B1

13A2

Yes

No

20Al

Yes

Yes

24Al

Yes

.No

Yes

No

No

No

21B1

24B1

SupMl-16

24B2

SupMl-18

27B1

SupMl-17
SupMl-19

No

19Al

16Al

SupMl-13

SupMl-15

Yes

No

Yes

19A2

SupMl-14

Yes

No

Yes

SupMl-11

SupMl-12

Yes

Yes
No

Yes

Yes

25B1

Yes

29A

Yes

No

Yes
No

No
No

No

Table 5. Table of spontaneous suppressors, ability to sporulate and degradation pattern.

Expression of HopMl in Some Haploid Suppressors Show
Degradation of the Protein

HopMl is unstable at 30 °C and 37° C resulting in
degraded fragments of HopMl in the cell (chapter 2).

HopMl

is only stable at 21° C and only is lethal at 21° C (chapter
2). Each strain was examined by Western blot analysis to
determine if the HopMl in each strain was stable or
degraded at 21°C.
The suppressor strains containing the plasmids pJB2
and pJB3 were grown to approximately mid-log phase in
minimal selective media. Galactose was added to the media
to induce the production of HopMl. Aliquots were taken at
O, 1, 3, 24 and 48 hours and whole cell protein extracts
were prepared and separated using an 8% SDS polyacrylamide
gel. The resulting gel was transferred to a PVDF membrane
and probed with the antibody for VS, an engineered c
terminal epitope on HopMl.
Figures 15-24 show the results obtained from the
western blot analysis of the suppressors. The expected
molecular weight of HopMl is 75kDa. As shown in figures 1517, we observe that SupMl 1, 4, 8, 11, and 12 show some
degradation of HopMl even when grown at 21 ° C.

While we

cannot conclusively attribute this to why suppression is
occurring, it is likely that there is not sufficient HopMl
present to cause lethality.

Thus these suppressor strains
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may only cause suppression by destabilizing HopMl further.
In figures 18-24 we observe that Sup 2, 3, 5-7, 9, 10, 1317, and 19 show no degradation of the HopMl protein. The
maximal production of HopMl in each of the suppressor
strains can be observed in the respective figures. Table 5
shows the combined results of suppressors that are able to
sporulate and the stability of HopMl protein in each
suppressor strain.
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Figure 15. HopMl is produced in WT and in suppressor SupMl4 and SupMl-11. Yeast strain JGY4, SupMl-4 and SupMl-11
containing both HopMl plasmids (pJB2 and pJB3) were induced
with galactose at time zero, aliquots were taken and
protein extracts prepared. The levels of HopM1-V5 in un
induced and induced cultures were determined by
immunoblotting. Molecular weight marker is shown. HopMl
produces a band at the expected molecular weight of 75kDa,
whereas SupMl-4 and SupMl-11 shows a degradation of the
HopMl protein.
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Figure 16. HopMl is produced in WT and in suppressor SupMl8 and SupMl-12. Yeast strain JGY4, SupMl-4 and SupMl-11
containing both HopMl plasmids (pJB2 and pJB3) were induced
with galactose at time zero, aliquots were taken and
protein extracts prepared. The levels of HopMl-VS in un
induced and induced cultures were determined by
immunoblotting. Molecular weight marker is shown. HopMl
produces a band at the expected molecular weight of 75kDa,
whereas SupMl-8 and SupMl-12 shows a degradation of the
HopMl protein.
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Figure 17. HopMl is produced in WT and in suppressor SupMl1. Yeast strain JGY4 and SupMl-1 containing both HopMl
plasmids (pJB2 and pJB3) were induced with galactose at
time zero, aliquots were taken and protein extracts
prepared. The levels of HopMl-VS in un-induced and induced
cultures were determined by immunoblotting. Molecular
weight marker is shown. HopMl produces a band at the
expected molecular weight of 75kDa, whereas SupMl-1 shows a
degradation of the HopMl protein.
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Figure 18. HopMl is produced in WT and in suppressor SupMl7 and SupMl-17. Yeast strain JGY4 and SupMl-7 and SupMl-17
containing both HopMl plasmids were induced with galactose
at time point zero, aliquots were taken and protein
extracts prepared. The levels of HopMl-VS in un-induced and
induced cultures were determined by immunoblotting.
Molecular weight marker is shown. HopMl, SupMl-7 and SupMl17 produce a band at the expected molecular weight of
75kDa.
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Figure 19. HopMl is produced in WT and in suppressor SupMl13 and SupMl-14. Yeast strain JGY4 and SupMl-13 and SupMl14 containing both HopMl plasmids were induced with
galactose at time zero, aliquots were taken and protein
extracts prepared. The levels of HopMl-VS in un-induced and
induced cultures were determined by irnrnunoblotting.
Molecular weight marker is shown. HopMl, SupMl-13 and
SupMl-14 produce a band at the expected molecular weight of
75kDa.
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Figure 20. HopMl is produced in WT and in suppressor SupMl15 and SupMl-16. Yeast strain JGY4 and SupMl-15 and SupMl16 containing both HopMl plasmids were induced with
galactose at time zero, aliquots were taken and protein
extracts prepared. The levels of HopMl-V5 in un-induced and
induced cultures were determined by immunoblotting.
Molecular weight marker is shown. HopMl, SupMl-15 and
SupMl-16 produce a band at the expected molecular weight of
75kDa.
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Figure 21. HopMl is produced in WT and in suppressor SupMl11 and SupMl-9. Yeast strain JGY4 and SupMl-10 and SupMl-9
containing both HopMl plasmids were induced with galactose
at time zero, aliquots were taken and protein extracts
prepared. The levels of HopMl-VS in un-induced and induced
cultures were determined by immunoblotting. Molecular
weight marker is shown. HopMl, SupMl-11 and SupMl-9 produce
a band at the expected molecular weight of 75kDa.
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Figure 22. HopMl is produced in WT and in suppressor SupMl2 and SupMl-3. Yeast strain JGY4 and SupMl-2 and SupMl-3
containing both HopMl plasmids were induced with galactose
at time zero, aliquots were taken and protein extracts
prepared. The levels of HopMl-V5 in un-induced and induced
cultures were determined by irnrnunoblotting. Molecular
weight marker is shown. HopMl, SupMl-2 and SupMl-3 produce
a band at the expected molecular weight of 75kDa.
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Figure 23. HopMl is produced in WT and in suppressor SupMl5 and SupMl-6. Yeast strain JGY4 and SupMl-5 and SupMl-6
containing both HopMl plasmids were induced with galactose
at time zero, aliquots were taken and protein extracts
prepared. The levels of HopMl-VS in un-induced and induced
cultures were determined by immunoblotting. Molecular
weight marker is shown. HopMl, SupMl-5 and SupMl-6 produce
a band at the expected molecular weight of 75kDa.

88

0

HopM1
3
24

48

0

1

SupM1-19
3
24

48

hr

-

83kDa_

62kDa_

475kDa_

Figure 24. HopMl is produced in WT and in suppressor SupMl19. Yeast strain JGY4 and SupMl-19 containing both HopMl
plasmids were induced with galactose at time zero, aliquots
were taken and protein extracts prepared. The levels of
HopMl-VS in un-induced and induced cultures were determined
by immunoblotting. Molecular weight marker is shown. HopMl
and SupMl-19 produce a band at the expected molecular
weight of 75kDa.
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Localization of HopMl in Suppressor Strains
As described in Chapter 2, HopMl localizes to the
organelles or vesicles of the secretory pathway. HopMl
appears in punctate like structures in the cytoplasm of
wild type yeast expressing HopMl with no obvious
localization to the nucleus. The suppr.essor strains
containing the HopMl plasmid were induced with galactose
and prepared for indirect immunofluorescence. We observed
no difference in localization of HopMl in any of our
suppressor strains as shown in Figures 25-37. In each
suppressor strain, HopMl localized to punctate structures
in the cytoplasm with no obvious localization to the
nucleus, beginning at hour 1.
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Figure 25. Localization of HopMl in WT and suppressor yeast
strain SupMl-2. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-2 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 26. Localization of HopMl in WT and suppressor yeast
strain SupMl-3. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-3 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 27. Localization of HopMl in WT and suppressor yeast
strain SupMl-5. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-5 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 28. Localization of HopMl in WT and suppressor yeast
strain SupMl-6. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-6 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 29. Localization of HopMl in WT and suppressor yeast
strain SupMl-7. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-7 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Irnrnunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 30. Localization of HopMl in WT and suppressor yeast
strain SupMl-9. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-9 were grown in selective media
containing 2% raffinose. HopMl was induced after time point
zero with the addition of 2% galactose. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for 2
hours. Immunofluorescence was used to visualize the VS
epitope and DAPI to visualize DNA respectively.
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Figure 31. Localization of HopMl in WT and suppressor yeast
strain SupMl-10. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-10 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.
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Figure 32. Localization of HopMl in WT and suppressor yeast
strain SupMl-13. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-13 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.

98

HrO

Hr3

Hr1

Hr 24

WT
(HopM1)

SupM1-14
(HopM1)

SupM1-14
(DNA)

Figure 33. Localization of HopMl in WT and suppressor yeast
strain SupMl-14. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-14 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Irnrnunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.
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Figure 34. Localization of HopMl in WT and suppressor yeast
strain SupMl-15. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-15 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.
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Figure 35. Localization of HopMl in WT and suppressor yeast
strain SupMl-16. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-16 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.
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Figure 36. Localization of HopMl in WT and suppressor yeast
strain SupMl-17. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-17 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.
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Figure 37. Localization of HopMl in WT and suppressor yeast
strain SupMl-19. Yeast strain JGY4 containing HopMl (pJB3)
and suppressor strain SupMl-19 were grown in selective
media containing 2% raffinose. HopMl was induced after time
point zero with the addition of 2% galactose. Aliquots were
taken at each time point and fixed with 3.7% formaldehyde
for 2 hours. Immunofluorescence was used to visualize the
VS epitope and DAPI to visualize DNA respectively.

Titer Assay of HopMl Suppressor Strains

In the wild type yeast strain, as described in chapter
2, we observed that HopMl produced a slow lethal outcome on
the yeast cells at 21° C. At hour 24 after induction with
galactose, 91% of initial viable cells were remaining and
this dropped to 37.5% initial viable cells at hour 48. To
determine if there is a change in the trend of the growth
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rates of the HopMl spontaneous suppressor strains, we
examined all strains that expressed full length HopMl.

We

examined the number of cells able to grow on solid dextrose
media after being removed from galactose induction. Figures
38-41 show the results for each strain. A majority of the
suppressors were able to survive the HopMl imposed
lethality as seen by the increase in the percent of initial
viable cells following galactose induction thru hour 6 (for
SupMl-2, SupMl-3 and SupMl-14) and thru hour 24 (for SupMl5 -7, SupMl-9 -10, SupMl-13, SupMl-15 -17 and SupMl-19).
One of the suppressors, SupMl-16 (Figure 39), showed a
tremendous increase in the percent of initial viable cells
from 117.94% at hour 6 to 4205.12% at hour 24.
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Figure 38. Examination of cell viability of yeast strains
containing HopMl. Yeast strain JGY4 containing HopMl or
control plasmid and suppressor strains (SupMl-16, SupMl-17
and SupMl-7) containing HopMl were grown in selective
medium containing 2% raffinose. 2% galactose was added to
the medium at the zero time point to induce HopMl
production. 1ml aliquots were taken at each time point,
sonicated and serially diluted onto SD-ura-leu plates to
identify cells that were able to grow.
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Figure 39. Examination of cell viability of yeast strains
containing HopMl. Yeast strain JGY4 containing HopMl or
control plasmid and suppressor strains (SupMl-2, SupMl-6
and SupMl-13) containing HopMl were grown in selective
medium containing 2% raffinose. 2% galactose was added to
the medium at the zero time point to induce HopMl
production. 1ml aliquots were taken at each time point,
sonicated and serially diluted onto SD-ura-leu plates to
identify cells that were able to grow.
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Figure 40. Examination of cell viability of yeast strains
containing HopMl. Yeast strain JGY4 containing HopMl or
control plasmid and suppressor strains (SupMl-5, SupMl-3
and SupMl-10) containing HopMl were grown in selective
medium containing 2% raffinose. 2% galactose was added to
the medium at the zero time point to induce HopMl
production. 1ml aliquots were taken at each time point,
sonicated and serially diluted onto SD-ura-leu plates to
identify cells that were able to grow.
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Figure 41. Examination of cell viability of yeast strains
containing HopMl. Yeast strain JGY4 containing HopMl or
control plasmid and suppressor strains (SupMl-14, SupMl-15,
SupMl-19 and SupMl-9) containing HopMl were grown in
selective medium containing 2% raffinose. 2% galactose was
added to the medium at the zero time point to induce HopMl
production. 1ml aliquots were taken at each time point,
sonicated and serially diluted onto SD-ura-leu plates to
identify cells that were able to grow.
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Creation of Genomic Library

To identify the gene(s) responsible for suppression of
the HopMl phenotype in the suppressor strains, we created a
genomic library that contained all genes in the suppressor
strain. Based on the results from the titer assay, which
showed that SupMl-16 showed a significant increase in the
percent of initial viable cells as compared to the wild
type strain containing HopMl, we decided to clone the
gene(s) responsible for growth of that suppressor strain.
Genomic DNA was partially digested with Sau3A and cloned
into the centromeric plasmid vector pRS313. We tried 5
different times using different methods but each time after
ligating the partially digested DNA into the vector, we
obtained resealed vector that did not integrate the insert.
We tried dephosphorylating the ends (removal of 5'
phosphate) utilizing shrimp alkaline phosphatase and
partially filling the overhang ends of the vector after
digesting with Sau3A and Xhol to prevent the vector from
resealing. Each method was 3 times with no result.
Identification of Gene(s) Responsible for Suppression
by Whole Genome Sequencing

Lack of success in creating a library led us to
consider alternative methods. Current sequencing abilities
have decreased the cost that it is no longer cost-
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prohibitive to sequence the entire genome of yeast. We
contracted with Otogenetics to sequence our wild type
strain as a control and one suppressor strain, SupMl-16.
Genomic DNA for yeast strain JGY4 and SupMl-16 were
prepared and sent off for sequencing. Saccharomyces
cerevisiae has 12,071,326 bases. 475,207,000 bases were
sequenced for strain JGY4, with an average of l00bp per
read and 40 repeats per read. 79.5% were mapped reads and
the remaining 20.5% were attributed to repetitive
sequences, ribosomal RNA, primers and low quality reads.
583,978,000 bases were sequenced for strain SupMl-16. The
average base length that was read was l00bp with 40 repeats
per read. For strain SupMl-16, there was 81.93% mapped
reads. The remaining 18.07% non-mapped reads were from
repetitive sequences, ribosomal RNA, primers and low
quality reads.
Analysis of Sequence Data

Examining the sequence data, we saw that the WT strain
had 5555 base changes and data from SupMl-16 showed 5391
base changes. These changes were based on comparing the
each strain against the original reference sequence of
Saccharomyces cerevisiae. Our strain is related, but has
likely diverged since it has been passed from lab to lab
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for the past 20 years or so. We filtered thru the data and
compared the sequence data of SupMl-16 against the sequence
of the WT strain, as this is the background strain our
suppressors were created in. We discarded changes in bases
that were the same in the wild type and SupMl-16, after
which this left us with 146 possible mutations found in
SupMl-16. Table 6 shows a summary of the results obtained
for the 2 strains. After examining the sequence data, and
based on our knowledge that we have to account for common
sequence errors, misalignment from computer algorithm and
the likelihood that a given change would result in a
particular mutation we found 8 changes (6 genes) that could
be responsible for the suppression seen in the mutant
(Table 7). Based on the size of the yeast genome and the
mutation rate of 10 7 , the number of mutations we obtained is
relatively close to the number that is expected.
Strain
WT
SupMl-16

Initial
Change

Filtered

5555

0

5391

146

Potential
Genes
0

6

Table 6. The two yeast genomes that were sequenced.·
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The simplest scenario is that only one of the 6
identified genes with a mutation is the gene responsible
for suppression of HopMl in the SupMl-16 strain.

To

determine which gene is responsible, we prioritized the
genes based on what we know about HopMl and its location in
the cell. RPS25A is nearly homologous to RPS25B and as such
not likely responsible (Planta and Mager, 1998). YGR064W is
a dubious open reading frame that does not likely encode a
protein. Furthermore it overlaps SPT4 on the opposite
strand.

SPT4 and NETl are nuclear proteins (Rondon et al.,

2004, Straight et al., 1999) and since we see no evidence
of localization to nucleus, these were least likely to be
responsible. tT(UGU)Ql is a tRNA in mitochondria, and since
there is no HopMl effect in the mitochondria, this is not
likely as well (Foury et al., 1998). This leaves us with
RSP5 remaining as a likely candidate for SupMl-16.
Potential
Identity
Genetic
Change that
Gene
change
occurred
E3
G-+T
Gly
Val
RSP5
Ubiquitin Ligase
Met
SPT4
A-+C
Arg
Suppressor of Ty's
YGR064W Dubious open reading
His
Pro
A-+C
frame
NETl
Ser
C-+T
Leu
Nucleolar silencing
establishing factor and
telophase regulator
RPS25A
A-+G
Ribosomal Protein of the
UTR
Small Subunit
tT(UGU)Ql Mitochondrial Threonine
Deletion
UTR
tRNA
Table 7. The potential genes identified from sequencing and
data analysis of SupMl-16.

---
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RSP5 is an E3 Ubiquitin Ligase that is involved in
regulating many cellular processes such as multivesicular
body sorting, heat shock response, ubiquitination, and
endocytosis (Wang et al., 1995). Nomura et al., 2006, have
suggested that HopMl acts as an adaptor that targets
Arabidopsis thaliana AtMIN7 (a guanine· nucleotide exchange
factor) to the proteasome for degradation. Our results
(chapter 2) show that HopMl localizes to organelles or
vesicles of the secretory pathway.

Thus we have continued

with RSP5 as a likely candidate and will reassess as we
proceed.
We utilized PCR to amplify RSP5 from genomic DNA that
was obtained from SupMl-16 using the forward and reverse
primer listed in table 8. We engineered a SacI restriction
enzyme site onto our reverse primer to allow for ease of
cloning into the yeast vector pRS313. Our forward primer
contained a HindIII restriction enzyme site. Once the gene
was amplified and verified, it was ligated into the yeast
vector and transformed into DHSa cells. Clones were
processed and sequenced to verify that they contained the
Glycine to Valine mutation that was determined from
sequencing of the suppressor genome, and did not contain
any other mutation. Table 8 shows the oligonucleotides used
for PCR amplification and sequence verification.
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The correct clones were transformed into the yeast
strain expressing 2 HopMl plasmids to look for suppression.
Results at present are inconclusive. RSP5 does not seem to
be suppressing the effects of HopMl, however there are a
number of reasons behind this. One reason is the presence
of the WT copy of RSP5 in our yeast strain. One way to
overcome this would be to over express the mutant copy of
RSP5 and ,look for suppression. If we see suppression, we

would have successfully identified the suppressor gene. If
RSP5 does not suppress the effects of HopMl, we will return

to the other 5 potential genes_(listed in table 7) and pick
another one to clone and repeat the process until we
identify the genetic change that is responsible for
suppression.

Oligonucleotide

Sequence

AGTTTGAGGAAAGCTTGGGAGAG
RSPS-Fl
GACGACGAGCTCGTAGGTGACTGGCAAGAGAG
RSPS-Rl
CGATCATGTGATCTTACGTAC
RSPS-1
GAAGCACATTTTGCAAGTGA
RSPS-2
RSPS-3
CCGTTCCCCGGATCCGT
RSPS-4
CGTCAAGTCCGCATTCAC
RSPS-5
CCAACGCTCGATCAAACAG
CCGGTCTCCCAATTAGGT
RSPS-6
RSPS-7
CGGTGGTGTTTCCAGAG
GGTGAAGTTGTAACAGTGGA
RSPS-8
RSPS-9
CTTCTCGTATACCTGTCAAC
RSPS-10
AGCAACATGGAAAGCAGC
Table 8. List of oligonucleotides used for sequence
verification.
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Discussion
The suppressor assay developed was successful in
producing spontaneous suppressors of HopMl imposed
lethality. We were able to identify 19 haploid spontaneous
suppressor strains that were capable o·f surviving the HopMl
imposed lethality. Of the 19, three of the suppressors,
SupMl-1, SupMl-11 and SupMl-18 were not able to sporulate.
These suppressors were not considered further.
Characterization of the suppressors has focused on
determining: stability of HopMl in each suppressor strain
and localization of HopMl in the suppressor strains. On
examining our results, we discovered that five of the
suppressors (SupMl-1, SupMl-4, SupMl-8, SupMl-11 and SupMl12) produced degradation products of the HopMl protein.
While this may be telling us something important about the
mechanism, we decided to focus on the remaining 13 (SupMl2, SupMl-3, SupMl-5, SupMl-6, SupMl-7, SupMl-9, SupMl-10,
SupMl-13, SupMl-14, SupMl-15, SupMl-16, SupMl-17, and
SupMl-19), which produced full length HopMl (75kDa) with no
degradation. We chose to discontinue analysis of
suppressors SupMl-1, SupMl-4, SupMl-8, SupMl-11 and SupMl12 from further characterization, as we were concerned that
these suppressors were able to survive due to not having
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full length HopMl present and showed a similar degradation
)

pattern of HopMl at 30° C and 37° C. The rationale behind
discarding these suppressors is due to the probability of
these suppressors functioning as proteases and therefore
degrading the HopMl protein, thus allowing the yeast to
survive the HopMl imposed lethality be·cause full length
HopMl is no longer present.
Examination of HopMl localization in the remaining 13
suppressors showed staining in punctate regions in the
cytoplasm.

We presume these are secretory organelles as

described in an earlier chapter (see chapter 2). From
looking at each of the suppressors, we found no difference
in localization of HopMl in the suppressor strains as
compared to wild type. We began to see localization of
HopMl to punctate like structures beginning at hour 1 thru
hour 24, with no obvious localization to the nucleus.
We utilized the titer assay in order to determine if
there was a change in growth rates of the suppressor
strains containing HopMl plasmids compared to wild type
containing HopMl plasmids. We observed that one of the
suppressors, SupMl-16, showed a significant difference in
growth rate. At hour 6 there are about 117.94% of initial
viable cells present and at hour 24, this number increases
to 4205.12% as compared to 110.56% and 75.60% present at
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the respective time points for HopMl in the wild type
strain. Due to the difference in growth and ability to
survive the HopMl lethality, we picked this suppressor
strain as a candidate to move forward with identification
of the suppressor gene or genes.
The entire genome of SupMl-16 was·sequenced and
compared to the wild type background (JGY4) that the
suppressors were created in. On comparison, we identified 6
genes that could be responsible for suppression. We
selected the gene RSP5 to begin the identification process.
RSP5 was selected based on a multitude of factors. Firstly,

research done by Nomura et al, 2006 in Arabidopsis thaliana
indicates that HopMl serves as a possible adaptor for
AtMIN7, a guanine nucleotide exchange factor and targets it
to the 26S proteasome (Nomura et al, 2006, Pickart, 2001)
for degradation.
On looking at the sequence of RSP5 and comparing it to
the published sequence, we observed a single base pair
mutation in the HECT domain at position 753 that causes a
change from a Glycine to a Valine. Both amino acids are
non-polar amino acids with the exception of the side chain
of Valine being slightly longer than that of Glycine. This
change in amino acid could possibly change the way
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ubiquitin forms the thioester bond with the conserved
Cysteine that is 24 amino acids away from the mutation.
RSPS is an E3 ubiquitin ligase that is involved in
regulating many cellular processes such as multivesicular
body sorting, heat shock response, ubiquitination of
substrates and shuttling them to the proteasome, and
endocytosis (Wang et al., 1999, Pickart, 2001, Shirssekar
et al., 2010). A literature search indicated that SEC7,
GEAl and GEA2 are the three yeast homologs of guanine
nucleotide exchange factors (GNEF) for ADP ribosylation
factors that are involved in endocytosis (Achstetter et
al., 1988). We hypothesize that either one of these
homologs binds to HopMl and changes the conformation thus
preventing ubiquitin from interacting with RSPS and
disrupts the degradation process allowing vesicle formation
to occur normally. This disruption could possibly be caused
by either the mutation in the HECT domain of RSPS therefore
preventing ubiquitin from being transferred to the
conserved Cysteine site or by no longer being able to
accept ubiquitin from the E2 site. This fact also ties in
our discovery from an earlier chapter that HopMl localizes
to the mitochondria and organelles of the secretory
pathway.

118

Future work that could stem from this would be
utilizing the yeast two-hybrid system to determine whether
RSPS, HopMl and other components like SEC7, GEAl or GEA2
physically interact. Other possible work would be to
perform co-immunoprecipitation to determine if we can
identify any interaction between HopMl" and/or RSP5 with
SEC7, GEAl or GEA2 and therefore support our hypothesis
that HopMl binds to either of these cellular targets.
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CHAPTER 4

CONCLUSION

Work on this project began with very little
information available on HopMl, an effector protein of
Pseudomonas syringae pv. tomato DC3000. Throughout the
preceding chapters, I have been able to show that HopMl has
an effect and plays a significant role. With this work,
using Saccharomyces cerevisiae as a model system, I have
been able to show that HopMl shows a lethal phenotype at
21 °C and localizes to the organelles or vesicles of the
secretory pathway. Munkvold et al., 2008, published
research indicating that HopMl does not have an effect in
yeast at 30°C. The discrepancy in the findings stem from the
fact that their work was done at 30°C and ours was done at
21 °C. Another fact is that literature also indicates that
the effector proteins from Pseudomonas syringae pv. tomato
DC3000 do not elicit an effect in tomato plants at
temperatures higher than 25 °C but instead prefer cool and
moist climates to be able to elicit an effect (Preston,
2000).
Localization studies of HopMl, the identification of
spontaneous suppressors and the identification of the
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gene(s) responsible for the suppression of the HopMl lethal
phenotype have lead to the discovery that HopMl plays a
possible role in endocytosis and the secretory pathway.
Preliminary results indicate that RSP5 may be the gene
responsible for suppression. There is work still left to be
done to confirm this result, but we are confident that this
is true based on the findings as indicated by Nomura et al.
Work done by Nomura et al., 2006 has helped shed some light
on the function of HopMl. Their work showed that HopMl acts
as a possible adaptor that targets the guanine nucleotide
exchange factor and shuttles it to the proteasome for
degradation.
Future work that could stem from this work would be
genome sequencing of the remaining spontaneous suppressors
to identify other gene responsible for suppression and the
long term goal of possibly identifying a genetic or
biochemical pathway that is involved. All of this is needed
to help shed some light on the function of HopMl and its
role in the cell.
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